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ABSTRACT 
 
The cyclin-dependent kinase (CDK) inhibitors have been demonstrated to be an 
important component in the regulation of plant cell cycle.  Although they share a conserved CDK 
inhibitory region with a family of CDK inhibitors in mammals, the plant CDK inhibitors are very 
different from the animal and yeast CDK inhibitors.  Thus studies of the plant CDK inhibitors 
could provide insight on the molecular mechanisms regulating the cell cycle in plants as well as 
the differences between plants and animals. The research described in this thesis investigated the 
seven Arabidopsis CDK inhibitors ICKs in terms of transgenic expression, phosphorylation, 
stability and interactions with other proteins.  
ICKs were expressed in transgenic Arabidopsis plants as fusion proteins with the green 
fluorescent protein (GFP).  Consistent with the previous studies on ICK1, ICK2 and ICK4, 
overexpression of all seven ICKs inhibited plant growth and resulted in plants with serrated 
leaves and flowers with altered morphology.  A Survey based on large a number of independent 
transformants showed that GFP-ICK3 and GFP-ICK4 had weaker phenotypic effects compared 
to other GFP-ICKs.  The Western blotting results showed that all GFP-ICKs were expressed at a 
low level in general.  The levels of GFP-ICK3 and GFP-ICK4 were the lowest, suggesting that 
the weaker effects for ICK3 and ICK4 may partly be due to low protein levels.  Treatments with 
MG132, an inhibitor of the proteasome, resulted in moderate but clear accumulation of fusion 
proteins for ICK1, ICK5, ICK6 and ICK7 in plants, suggesting that the proteasome is involved in 
the degradation of these proteins.  
To study the state of protein phosphorylation, the proteins extracted from the plants were 
treated with calf intestinal phosphatase (CIP).  The CIP treatment caused a faster migration of the 
GFP fusion protein for ICK1, ICK2, ICK5, ICK6 and ICK7, while the effect was not observed 
for control GFP and other non-specific proteins, indicating that these proteins can be 
phosphorylated in plants.  The shift also differed among ICKs. Interestingly, dephosphorylation 
of ICK7 might have rendered it less stable.  The protein pulldown experiments using p13Suc1-
conjugated agarose beads showed that GFP-ICK4, GFP-ICK5 and GFP-ICK6 could associate 
with the CDK complex, similar to what has been shown for ICK1 and ICK2.  CIP treatments of 
the p13Suc1 affinity-purified proteins also showed that ICK1, ICK2, ICK5 and ICK6 associated 
with the CDK complex were phosphorylated.  
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Attempts were also made to isolate peptide aptamers that are able to interact with ICKs 
for the purpose for expressing such an aptamer in plants.  However, an aptamer that has a strong 
ability to interact with ICKs in two of yeast two-hybrid systems was not identified.  In addition, 
the analysis of Arabidopsis CYCD3;1 for its interaction with ICK1 using a series of deletion 
mutants showed that the removal of both the N-terminal and C-terminal regions of CYCD3;1 
greatly reduced or abolished the interaction with ICK1.   
 In summary, transgenic Arabidopsis plants have been obtained for expressing each of the 
seven Arabidopsis CDK inhibitors fused to GFP.  The results confirmed and extended previous 
finding that overexpression of a CDK inhibitor inhibits plant growth as well as changes plant 
morphology.  The observation that the ICK fusion proteins were generally at low and often 
undetectable levels, in comparison to much higher levels of the GFP protein, suggests that ICKs 
are unstable in the cell.  Results from the MG132 experiments indicate that the 26S proteasome 
may play a role in the degradation of ICK1, ICK5, ICK6 and ICK7.  Results from CIP treatments 
further show that most ICKs, particularly ICK1, ICK2, ICK5, ICK6 and ICK7, can be 
phosphorylated in vivo. Interestingly, ICK7 stability may depend on the status of protein 
phosphorylation.  This study provides new understanding on how the family of proteins is 
regulated at the post-transcriptional level and the differences among Arabidopsis CDK inhibitors.  
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CHAPTER 1: INTRODUCTION AND BACKGROUND 
 
1.1 Importance of studying cell cycle regulation in plants   
The regulation of the cell cycle in eukaryotes has been studied extensively throughout 
history due to its fundamental nature and its influence over many other processes such as 
differentiation, apoptosis, growth and development.  When one or more of these processes are 
not regulated precisely, the consequences can be dire for the organism in question.  Traditionally, 
most of the research and subsequent understanding of the cell cycle regulation is derived from 
animals and yeast.  Recently, more attention is being paid to the cell cycle regulation in plants.  
Why do we need to study cell cycle regulation in plants?   
Plants have characteristics that are very different from animals in cell cycle regulation.  
For instance, plants develop mainly post-embryonically.  A group of stem cells referred to as 
meristems, are where new cells are added to produce the organs of the plant.  Post-embryonic 
growth allows the plant to have greater flexibility to change in terms of organ number and size.  
Since body size is a function of the number and size of cells, plants are well suited for studying 
the effects of cell number and size on growth and development.   
Another characteristic of plants that is remarkably different from animals is the presence 
of the cell wall.  The cell wall provides strong structural support to the cell but in return restricts 
mobility or migration that occurs often in animals.  In addition, plants can not move, and thus 
must adapt and withstand adverse environmental conditions.  To successfully adapt to these 
environmental conditions and ensure survival, plants may have specific regulatory circuits that 
make the cell cycle regulation and cell proliferation sensitive to changes in environmental 
conditions.   
The ability of plants to continuously produce organs indeterminately makes them an 
interesting and useful system to study cell cycle regulation.  Plants normally do not show 
cancerous growth, except in some unique situations.  Agrobacterium tumefaciens, a bacterium 
that can insert a very large plasmid (Ti plasmid) into plants cells, can cause tumors that are 
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commonly referred to as crown galls in plants.  The T-DNA inserted by Agrobacterium 
tumefaciens encodes genes for plant hormones which can induce tumor formation in the plant.  
Although plant tissues are not immune to cancerous condition, as evident by Agrobacterium 
tumefaciens infection, the prevalence of tumor formation in plants is remarkably less than that of 
mammalian cells.  The ability of plants to control its cell cycle to ensure normal growth is of 
great interest to many researchers.  Understanding the control of cell cycle in plants is the first 
step in uncovering this mystery.   
 
1.2 Overview of cell cycle regulation in plants 
Regulation of the cell division cycle in plants is essential to ensure proper growth and 
development.  Plant cell cycle is controlled by an evolutionarily conserved family of serine-
threonine protein kinases, referred to as cyclin-dependent kinases (CDKs) (reviewed by Morgan 
1997; Joubes et al. 2000).  CDK activation requires the presence and binding of a regulatory 
partner, cyclin.  Upon binding to its cyclin partner, CDKs will phosphorylate a series of 
downstream targets including the retinoblastoma protein (Rb).  When Rb becomes 
phosphorylated, it dissociates itself from the E2F transcription factor (reviewed in de Jager and 
Murray 1999).  This allows E2F to activate transcription of various S phase-related genes and 
promoting the entry into a new cell cycle.    
To make the cell cycle control more complicated, the CDK-cyclin complex is further 
regulated by a group of CDK inhibitors (Sherr and Roberts 1999).  In plants, ICKs 
(Interactors/inhibitors of Cdc2 Kinase) or KRPs (Kip related proteins) were the first plant CDK 
inhibitors discovered by the yeast two-hybrid technique using Arabidopsis CDKA; 1 as bait 
(Wang et al. 1997; Lui et al. 2000; De Veylder et al. 2001; Zhou et al. 2002a). This family of 
proteins share only limited sequence similarity to the animal Kip/Cip family of CDK inhibitors.  
Thus, ICKs have provided us with a good tool and opportunity to further our understanding of 
the cell cycle regulation in plants.  This family of proteins is the focus of this thesis and 
background information of ICKs as well as the other major cell cycle regulators (CDKs, cyclins, 
Rb, E2F) will be discussed in the following sections. 
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1.3 Core regulators of the cell cycle 
1.3.1 Cyclin-dependent kinase (CDKs) 
CDKs play a central role in governing the cell cycle in eukaryotes, and their kinase 
activity generally depends on the association with cyclins (Pines 1995).  The first CDK was 
discovered as Cdc2 in fission yeast Schizosaccharomyces pombe (Hindley and Phear 1984) and 
as CDC28 (a Cdc2 homolog) (Lorincz and Reed 1984) in budding yeast Saccharomyces 
cerevisiae.  While only one CDK plays an essential role in regulating the cell cycle in yeast, 
multiple CDKs are involved in cell cycle regulation of plants and animals.  In animals, the 
nomenclature of CDK1 to CDK7 has been used (Pines 1995) while in plants, CDKs are 
classified into CDKA to CDKF types based upon sequence similarity (Joubes et al. 2000; 
Vandepoele et al. 2002).  Of the six types of plant CDKs, CDKA and CDKB are believed to be 
involved in regulating the cell cycle progression while CDKD and CDKF play a role in 
phosphorylating and activating the kinase activity of CDKA and CDKB (Harper and Elledge 
1998; Umeda et al. 1998). 
 
1.3.1.1 CDKA 
Plant CDKA is perhaps the most well known type of the CDK family in plants.  CDKA, 
yeast Cdc2/CDC28 and animals CDK1 all possesses the evolutionarily conserved PSTAIRE 
(single amino acid code) sequence motif within its cyclin-binding domain.  In fact, the sequence 
homology between plant CDKA and its yeast and mammalian counterpart is closer than between 
plant CDKA and other plant CDK members (i.e. CDKB).  CDKA is the only member of the 
plant CDK family that can complement yeast cdc2/cdc28 mutants (Ferreira et al. 1991; Hirt et al. 
1991; Imajuku et al. 1992).  The CDKA mRNA and protein levels do not change very much 
throughout the cell cycle (Martinez et al. 1992; Hemerly et al. 1993).  However, the kinase 
activity of CDKA in Arabidopsis is upregulated and remains high from G1 to S phase of the cell 
cycle, reduced in G2 and finally increases again at the G2/M transition (Menges and Murray 
2002).  Thus, CDKA seems to be required at both G1/S and G2/M transitions of the cell cycle.   
 
1.3.1.2 CDKB 
Plant CDKB seems to be unique to plants since no homologue of this gene has been 
identified in other species.  Contrary to CDKA which has the traditional PSTAIRE hallmark, 
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CDKB are subdivided into two groups possessing either the PPTALRE (CDKB1) or PPTTLRE 
(CDKB2) amino acid sequence (Joubes et al. 2000).  CDKB is an important regulator of the 
G2/M checkpoint as evident by the high kinase activity during G2/M transition (Magyar et al. 
1997).  Overexpression of a dominant negative CDKB leads to a substantial increase of G2 
population, suggesting that the G2/M transition is blocked (Porceddu et al. 2001).  Interestingly, 
overexpression of CDKB as well as other CDKs does not induce extra cell divisions (Hermerly 
et al. 1995; Boudolf et al. 2004).  Thus, the protein levels of CDKs do not seem to be the rate 
limiting factor for their activity.  Cyclins, which are the regulatory partners with CDKs, are most 
likely the limiting factor in controlling the kinase activity of CDKs (Doerner et al. 1996).   
 
1.3.1.3 CAK: CDKD/CDKF 
CDK-activating kinase (CAK) plays an important role in cell cycle regulation by 
phosphorylating and thus activating CDKA and CDKB.  In plants, two types of CAK have been 
identified: CDKD and CDKF.  CDKD is the plant homologue to yeast Crk1/Mop1 
(Schizosaccharomyces pombe), Kin28p (Saccharomyces cerevisiae) and human CDK7.  The 
CDK7 kinase has duel functions as it phosphorylates both CDKs and the C-terminal domain 
(CTD) of RNA polymerase II (Harper and Elledge 1998).  Rice R2, which is the first plant 
CDKD identified, displays the dual function of CDK7 and is capable of complementing a CAK-
deficient mutant of the budding yeast (Hata 1991; Yamaguchi et al. 1998).  In Arabidopsis, three 
CDKD genes have been identified and are named At;CDKD;1,  At;CDKD;2, and AtCDKD;3 
respectively.  One major structural difference between vertebrate CAK and plant CAK is the 
presence of an extended C-terminal region of 92 amino acids in plant CDKs.  This extended 
region of amino acids contains a nuclear localization signal (NLS) (Fabian-Marwedel et al. 
2002).  Studies using green fluorescent protein (GFP) fused to the At;CDKDs revealed that 
At;CDKD;1 and At;CDKD;3 were localized exclusively in nuclei, while At;CDKD2 was 
localized in both the cytoplasm and nuclei of plant cells (Shimotohno et al. 2004).   
CDKF is a plant-specific type of CAK-activating kinase isolated initially as a suppressor 
to CAK mutation in budding yeast (Umeda et al. 1998).  Unlike Rice R2, the Arabidopsis 
CDKF;1 can’t phosphorylate the CTD of RNA polymerase II and only has kinase activity 
towards At;CDKD;2 and At;CDKD;3.  In fission yeast, Csk1 has been shown to be able to 
phosphorylate CDK (Mcs6) and is commonly referred to as a CAK-activating kinase (CAKAK).  
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Only At;CDKF;1, but not any of the At;CDKDs, was able to complement fission yeast strain 
carrying a disrupted csk1∆ gene (Shimotohno et al. 2004).  Adopting the term from yeast, CDKF 
is a plant specific CDKAK that regulates the activity of At;CDKD;2 and At;CDKD;3.by 
phosphorylation. 
 
1.3.2 Cyclins 
Cyclins were first identified in marine invertebrates as proteins showing a ‘cyclical’ 
pattern of accumulation and degradation during each cell cycle (Evans et al. 1983).  Later it was 
discovered that cyclins are the regulatory partner of CDKs by binding to and activating CDK 
kinase activity (Meijer et al. 1989).  Cyclins are a diverse group of proteins that are classified 
into several types based upon sequence similarity.  The most common types include the A-type, 
B-type, D-type, and H-type (Renaudin et al. 1996).  All cyclins possess a large region of 
homology commonly referred to as the cyclin box.  The cyclin box is a stretch of about 100 
amino acids composing of 5 helices which are responsible for binding to CDKs (Nobel et al. 
1997).  Different cyclins have been found to interact with different CDKs (Nakagami et al. 1999, 
Healy et al. 2001, Yamaguchi et al. 2000).  In many cases the expression patterns and activity 
profile of plant cyclins during the cell cycle show similarity to those of the mammalian 
counterparts. 
 
1.3.2.1 A and B-type cyclins 
The functions of A and B-type cyclins appear to overlap and thus are often grouped 
together when describing them.  Both A- and B-type cyclins are considered to be mitotic cyclins, 
meaning that their protein levels accumulate around the G2/M transition point in the cell.  A-type 
cyclins generally appear before B-type cyclins at around the beginning of S phase and are 
present until the M phase where both type of cyclins are destroyed (Genschik et al. 1998).  The 
levels of A- and B-type cyclins are stringently controlled as both families of proteins contain a 
‘destruction box’ that targets them for degradation by the anaphase-promoting complex.   
In plants, A-type cyclins are subdivided into three subclasses:  CYCA1, CYCA2, and 
CYCA3 (Renaudin et al. 1996.)  The greater diversity of the cyclin class in plants as compared 
to animals (no subclass) may be related to the heightened level of regulation of the cell cycle due 
to the sessile characteristics of plants and the need to respond to both intrinsic and environment 
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cues.  One difference between the CYCA subclasses lies in the consensus sequence for the 
destruction box: A-type (RxA/PLxNL/IxN), B-type (RAV/ILxDxxN) and C-type 
(RVVLGEL/IxN) (Renaudin et al. 1998).  This difference suggests that each subclass may have 
distinct role in the cell cycle regulation as the timing of their expression/degradation pattern may 
be different.  
Similar to animals, B-type cyclins in plants are divided into two groups: CYCB1 and 
CYCB2.  Apart from their differences in amino acid sequence, B-type cyclins distinguish 
themselves from the A-type cyclins by their later expression in the cell cycle.  The regulation of 
G2/M checkpoint by B-type cyclins has been well demonstrated (Qin et al. 1996; Schnittger et al. 
2002).  As well, ectopic expression of CYCB2 stimulates the cells into mitosis from G2 and 
affects root and shoot development (Weingartner et al. 2003).  In the promoter region of B-type 
cyclins, a common cis-acting element, called the M-specific activator (MSA) was discovered that 
is capable of directing G2 to M specific gene expression (Ito et al. 1998).   
 
1.3.2.2 D-type cyclins 
D-type cyclins are considered to be G1 cyclins and their presence is required for the G1 
to S transition.  In Arabidopsis, D-type cyclins are divided into 3 subclasses: CYCD1, CYCD2, 
and CYCD3.  The overall sequence homology between the plants CYCD to its mammalian 
counterpart is very low, but they do share an important feature, the Rb protein binding motif, 
LxCxE (where x can be any amino acid).  The LxCxE motif of CYCD is essential for 
CYCD/CDK complex to bind and phosphorylate Rb (Dowdy et al. 1993).  In addition to the 
LxCxE motif, D-type cyclins also possess the PEST (proline, glutamine, serine and threonine 
rich) sequence.  The PEST sequence is known to be associated with unstable, rapidly degrading 
proteins.  Arabidopsis CYCD3;1 which possess the PEST sequence were found to be a very 
unstable protein with a half life estimated at 7 min (Planchais et al. 2004).  Interestingly, 
CYCD2;1 which also possesses the PEST sequence turns out to be a rather stable protein 
(Planchais et al. 2004).  Similar to mammals, plant D-type cyclins are degraded through a 
proteasome-dependent mechanism, specifically the ubiquitin/26S proteasome pathway 
(Planchais et al. 2004).   
The expression of D-type cyclins has been shown to be modulated by plant growth 
factors such as cytokinins, brassinosteroids, sucrose and gibberellins (Stals and Inze 2001).  It 
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has been shown that the expression of CYCD2 and CYCD3 genes is induced by sucrose and this 
induction appears to be mediated by a phosphatase (Riou-Khamlichi et al.  2000).  Although 
CYCD2 and CYCD3 appear to function in the G1 to S transition and interact with the same CDK 
partner, they appear to be regulated differently.  While the expression of both CYCD2;1 and 
CYCD3;1 expression is regulated by sucrose, CYCD3;1 but not CYCD2;1 shows strong 
response to plant hormones (Riou-Khamlichi et al. 2000).  As well, the protein level of CYCD3 
degrades rapidly upon sucrose removal, a direct correlation to its declining mRNA level.  In 
contrast, the protein level of CYCD2 does not correlate to its mRNA level and the protein is 
relatively stable upon sucrose removal (Riou-Khamlichi et al. 2000).  These observations suggest 
that CYCD2 is regulated post-translationally, whereas CYCD3 is regulated mainly on the 
transcript level.   
 
1.3.2.3 H-type cyclins 
Plant H-type cyclins are the regulatory subunit of CAK (CDKD and CDKF) and shares 
40-60% sequence homology with the mammalian counterpart.  In rice and poplar, high transcript 
levels of CYCH were observed with dividing cells (Yamaguchi et al. 2000).  Yeast two-hybrid 
analysis reveals that rice CYCH interacts with Rice R2 kinase and not with other rice CDKs 
(Yamaguchi et al. 2000).  Recently, CYCH has been shown to form a stable complex with 
CDKD;2, but not CDKD;3, and its kinase activity is downregulated by WEE1 kinase 
(Shimotohno et al. 2006).   
 
1.3.3   Cyclin-dependent kinase inhibitors (CKIs) 
Another component that plays a prominent role in regulating the cell cycle in eukaryotes 
is the CKI.  Binding of a CKI to the CDK/cyclin complex can modulate the CDK activity. CKIs 
have been studied extensively in humans due to their potential role as tumor suppressors.  Plants 
also have CKIs, however much less is known about them in comparison to the mammalian CKIs.  
 
1.3.3.1  Comparison of mammalian CDK inhibitors vs plant CDK inhibitors 
In mammals, there are two families of CKIs, Kip/Cip family and INK4 family, which are 
different in their mode of action and sequence similarity (Sherr and Roberts, 1999).  The Kip/Cip 
family is composed of 3 members: p21Cip1, p27Kip1 and p57Kip2, while the INK4 family is 
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composed of 4 members: p16INK4a, p15INK4b, p18INK4c, and p19INK4d.  The Kip/Cip family appears 
to have a broader spectrum of inhibitory effects as it can form complexes with CDK4/6-cyclin D, 
CDK2/cyclin E, CDK1/2-cyclin A and CDK1/cyclin B (Toysoshima and Hunter 1994; Lee et al. 
1995).  This observation suggests that Kip/Cip plays a role in both G1 to S and G2 to M 
checkpoints in the cell cycle.  In contrast the INK4 family strictly targets G1 CDKs, CDK4 and 
CDK6.  The mechanism by which Kip/Cip and INK4 inhibit the kinase activity of CDK/cyclin 
complex is also different.  The INK4 protein prevents cyclin binding to CDK by causing an 
allosteric change in the region where the two proteins bind (Pavletich 1999).  In contrast, when 
Kip/Cip protein binds to CDK, it does not dissociate or prevent cyclin binding.  It inhibits the 
kinase activity by distorting the catalytic ATP-binding center of the CDK subunit (Pavletich 
1999).      
The first plant CDK inhibitors were isolated using the yeast two-hybrid technique using 
Arabidopsis CDKA;1 as the bait (Wang et al. 1997).  This family of proteins was thus named 
ICKs (inhibitors or interactors of CDK).  Another common name for this family of proteins is 
called KRPs (Kip-related proteins).  This name was given by a group of researchers who 
discovered the remaining members of the ICKs family by data mining the Arabidopsis genomic 
databases (De Veylder et al. 2001).  To avoid confusion, the name ICKs will be used exclusively 
for the rest of the thesis.   
In Arabidopsis, there are a total of seven ICK members in the family.   These ICKs have 
a region conserved among themselves as well as with the mammalian counterparts.  The region 
of similarity between ICKs and mammalian CKIs involves a stretch of 31 amino acids residues 
that are found in both ICKs and p27Kip1.  This region of amino acids appears to be essential for 
the inhibitory function of both ICKs and mammalian p27Kip1.  Apart from this region, ICKs 
differ greatly among themselves and also with the mammalian CDK inhibitors.  Thus far, no 
plant CKIs similar to the mammalian INK4 family of inhibitor have been found.   
 
1.3.3.2 Targets of ICKs: CDKA/CYCD complex 
Despite their low sequence similarity to mammalian CKIs, the ICKs have been shown to 
be potent inhibitors of CDK activity in vitro (Wang et al. 1997; Lui et al. 2000) and in vivo 
(Wang et al. 2000; De Veylder et al. 2001).  ICK1 exerts its inhibitory effect by binding to and 
interacting with both CDKA and D-type cyclins (Wang et al. 1998).  All ICKs from Arabidopsis 
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have been shown to be capable of interacting with D-type cyclins (De Veylder et al. 2001; 
Jasinski et al. 2002a; Zhou et al. 2002a) but not with mitotic cyclins (Zhou et al. 2002a) in the 
yeast two-hybrid system.  Furthermore, the phenotypic changes of transgenic plants 
overexpressing ICK1 can be partially rescued by co-overexpressing CYCD2 and CYCD3 (Zhou 
et al. 2003a), indicating that ICK1 also interacts with the D-type cyclins in plants.     
Besides ICK1, most of the other members of the ICK family appear to be able to also 
interact with CDKA.  In one yeast two-hybrid experiment, all ICKs except for ICK3 were able to 
interact with Arabidopsis CDKA (De Veylder et al. 2001).  Although in another yeast two-
hybrid experiment, ICK4 and ICK5 were not able to interact with the same CDKA (Zhou et al. 
2002a).  As suggest by Wang et al. (2006) this differences in results may be related to the 
sensitivity of different yeast two-hybrid systems used.  Additional and different techniques may 
be required to resolve the differences observed.  One consensus that was reached with all the 
yeast two-hybrid experiments is that none of the ICKs interact with CDKB;1 (De Veylder et al. 
2001; Jasinski et al. 2002a; Zhou et al. 2002a).  This observation is further supported 
biochemically by the observation that ICK2 overexpressed in transgenic plants only inhibits the 
activity of A-type CDK, but not that of B-type CDK (Verkest et al. 2005).  Summarizing the 
results from literature to date, it appears that plant CDK inhibitors most likely interact with 
CDKA and cyclin D and suppress the kinase activity of the CDKA/cyclin D complex.  
 
1.3.3.3 Expression patterns of ICKs at the transcript level 
Transcriptional regulation of genes is an important means to control the abundance and 
activity of the proteins.  Not surprisingly, the transcript levels of ICKs have been studied to see 
when, where and how much of the transcripts and proteins are present in plants.  Northern 
analysis of ICK1 and ICK2 has shown that the transcript levels of both genes are relatively low 
among the tissues tested: root, inflorescence, flower and seedlings (Lui et al. 2000).  Using 
reverse transcriptase-PCR (RT-PCR) to study the expression of ICK genes (De Veylder et al. 
2001) it was observed that ICK1 and ICK4 were present ubiquitously in all the tissues tested: 
root, inflorescence, flower, leaves and cell suspension.  While ICK3, ICK5 and ICK7 were also 
detected in all tissues, the level of expression seems to be higher with tissues that have higher 
mitotic activity (i.e. flowers, suspension cultures).  ICK2 was most abundant in flowers while 
ICK6 was only observed in cell suspension cultures.   
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The expression of ICKs has also been analyzed using in situ hybridization (Ormenese et 
al. 2004).  ICK1 and ICK2 expression is restricted to endoreduplicating tissues, suggesting they 
may specifically be involved in transition between mitotic cycle to endoreduplication cycle.  
ICK3 and ICK7 were expressed in all tissues where mitotic divisions occur, indicating that the 
expression of these genes may play a role in regulating the progression of the mitotic cell cycle.  
ICK4, ICK5 and ICK6 were all present in both mitotically dividing cells and endoreduplicating 
cells (Ormense et al. 2004).  This study provides evidence that ICKs exhibit differential 
expression patterns.   
 
1.3.3.4 Regulation of ICKs at post-transcriptional level 
Similar to its mammalian counterpart, ICKs are regulated at the post-transcriptional level 
to control the abundance of the protein.  In transgenic Arabidopsis plants overexpressing ICK1, 
the fusion protein level was low even though the mRNA level was high (Zhou et al. 2003b).  The 
N-terminal region of ICK1 appears to be important in regulating the stability of the protein.  The 
deletion mutant ICK1109-191 (amino acid 1-108 deleted) has been shown to interact with both 
CDKA and CYCD3;1 much stronger than full length ICK1 in the yeast two-hybrid system 
(Wang et al. 1998).  When the deletion mutant is overexpressed in transgenic plants, higher 
protein expression level was detected for the mutant than the full length ICK1.  Furthermore, the 
phenotypic effects of overexpression of the ICK1109-191 deletion mutant in transgenic Arabidopsis 
plants appear much more severe (i.e. smaller plant size and stronger leaf serrations) than the full 
length ICK1 (Zhou et al. 2003b).   
Post-transcriptional modification such as phosphorylation is one of many important 
regulatory mechanisms in eukaryotes.  The phosphorylation state of a protein often determines 
its cellular function and destiny in cells.  Quite often, the phosphorylation of a protein signals its 
degradation.  One way by which proteins are degraded is through ubiquitin-proteasome complex.  
The ubiquitin-proteasome pathway plays a critical role in controlling the proper protein level in 
eukaryotic cells.  Proteins that are targeted for degradation are marked by the covalent 
attachment of multiple ubiquitin molecules, a process called ubiquitylation (Review by Roos-
Mattjus 2004). The ubiquitylated proteins are recognized and eventually degraded by the 26S 
proteasome complex.    
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Mammalian and yeast CDK inhibitors have been shown to be phosphorylated by CDKs 
and subsequently targeted for degradation by the proteasome (Vlach et al. 1997; Tomoda et al. 
1999).  A recent study suggests that plant CDK inhibitors may also share this mode of regulation 
with the mammalian and yeast counterparts.  In one study, ICK2 was found to be phosphorylated 
by both CDKA;1 and CDKB;1 in vitro and that the level of recombinant ICK2 protein 
accumulates when a proteasome inhibitor, MG132 was added (Verkest et al. 2005).  Also, the 
proteolysis of ICK2 protein appears to be dependent on CDKB;1 kinase activity, since no 
destruction was observed in extracts incubated with olomoucine, a strong and specific inhibitor 
of CDK activity (Verkest et al. 2005).  Even though ICK2 appears to be subjected to proteolysis 
in a phosphorylation dependent manner, more work needs to be conducted to determine whether 
other ICKs behave in a similar manner.  Since ICKs appear to have different roles in regulating 
the cell cycle, it will be interesting to understand how their protein levels are regulated.  So far, 
only limited data are available mostly from in vitro experiments. 
 
1.3.3.5 Effects of ICK overexpression on plant growth and development 
The question of whether cell cycle regulators play a significant role in plant growth and 
development has always been a heavily debated subject.  Traditionally, the thinking was that cell 
division plays a minor role in morphogenesis of plants (Review by Kaplan and Hagemann 1991).  
Recently, more evidence suggests that cell division and plant development may be more 
intrinsically linked than previously thought (Review by Doonan 2000).  The overexpression of 
ICKs has been shown to severely affect cell cycle progression, but what effect does it have on 
the growth and development of plants?   Transgenic plants overexpressing ICK1, ICK2, ICK4, 
NtKIS1a (a tobacco ICK-related gene), and ICKCr (a Chenopodium ICK1-related gene) all 
display similar phenotypes, in that the leaves of the transgenic plants are serrated and the overall 
size of the plant is smaller compared to wild type plants (Wang et al. 2000; De Veylder et al. 
2001; Jasinski it al. 2002b; Zhou et al. 2002a).  It is easy to understand why the plants would be 
smaller due to inhibition of the cell cycle, but why are the leaves serrated?  Perhaps the strong 
reduction in cell number due to cell division inhibition also contributes to this phenotype in the 
more sensitive ‘teeth’ region of the leaves.  Nevertheless it appears that manipulation of ICK 
protein level can affect organ morphogenesis.  This idea is further reinforced by the study of 
targeting ICK1 expression in petal primordial of Brassica plants using the Arabidopsis AP3 
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(APETALA3) promoter (Zhou et al. 2002b).  Some of the petals in the transgenic plants were 
severely altered into tubular shapes (Zhou et al. 2002b).  ICK1 has also been expressed in pollen 
using a pollen specific promoter.  While no phenotypic changes can be observed, the pollen 
viability decreased resulting in reduced fertility indicating that ICK1 expressions play a role in 
affecting nuclear division during pollen development (Zhou et al. 2002b).   
The above results regarding the effects of ICKs are obtained with transgenic 
overexpression. It is not clear at present about the physiological concentrations of ICKs and their 
effects in wild type Arabidopsis plants. One approach to determine the functions of ICKs in 
normal plants is to study T-DNA insertion mutants in which the expression of gene of interest is 
knocked out. However, no phenotype has been reported with any of the ICKs when its function 
is disrupted (Wang et al. 2006).  
 
1.3.3.6 Level of ICKs controls cell cycle progression, endoreduplication and cell cycle exit 
Cell division in eukaryotes is divided into four sequential ordered phases: S phase (DNA 
replication), M phase (mitotic division) and in between them are two gap phases (G1 and G2) 
that are important to ensure that the previous phase has been accurately and fully completed 
before proceeding to the next phase.  Once the cells finish DNA replication, they pause in G2 
phase to ensure proper criteria are met before embarking on mitotic division.  It is interesting to 
note that in some cases, cells after finishing DNA replication will not proceed to the mitotic 
division phase, but rather repeat the replication of DNA.  This process is called 
endoreduplication, simply defined as duplication of genomic DNA without mitosis (Joubes and 
Chevalier 2000).  In plants, endoreduplication is widespread and in Arabidopsis, the ploidy 
levels can be up to 32C in the final stages of leaf development (Galbraith et al. 1991).   
The decision of the cell to undergo mitotic division or endoreduplication is under the 
control of cell cycle regulators.  In Arabidopsis, overexpression of an ICK inhibits 
endoreduplication in leaves (De Veylder et al. 2001; Jasinski et al. 2002b; Zhou et al. 2002a).  
Since ICKs target CDKA and D-type cyclins, CDKA and D-type cyclins may be important for 
endoreduplication.  Consistent with this idea, it was observed that a dominant negative mutant of 
CDKA reduces endoreduplication in maize endosperm (Leiva-Neto et al. 2004).  As well, 
CYCD3 expression level increases in endoreduplicating maturing tomato tissues, suggesting that 
 12
some D-type cyclins are involved in endoreduplication by promoting the G1 to S transition 
(Joubes and Chevalier 2000).   
Recently it was observed that different expression levels of ICKs may be critical in 
determining whether a cell undergoes cell cycle progression, endoreduplication or cell cycle 
arrest.  In wild type plants where the protein level of ICKs are relatively low, cell cycle 
progression is permitted.  In transgenic plants weakly overexpressing ICK2, entry into mitosis is 
blocked but progression through S-phase is still allowed resulting in an increase in DNA ploidy 
levels (Verkest et al. 2005).  Comparatively, in transgenic plants strongly overexpressing ICK2, 
CDK activity is inhibited in both mitotically dividing and endoreduplicating leaf tissues, and the 
ploidy level was lower than transgenic plants weakly expressing ICK2 (Verkest et al. 2005).  
The contradicting effects of ICKs on ploidy level may be due to two possibilities (Wang et al. 
2006).  Either higher levels of CDK/cyclin activity are required for entry into mitosis than for 
entry into S-phase or ICK2 has a higher affinity for an inhibitory effect on mitotic cyclin/CDK 
complexes.  Thus it appears that the level of ICKs dictates which cell cycle pathway the cell 
takes, mitotic versus endoreduplication.  A low level of ICK inhibits mitotic cycles but permits 
endocycles, whereas a higher level of ICK inhibits the endocycle resulting in lower ploidy levels.     
 
1.4 G1 to S transition.   
One critical stage for the regulation of the cell cycle in eukaryotes is G1 to S transition. 
G1 to S entry is initiated by the synthesis of D-type cyclins upon mitogenic stimulation.  In 
plants, the protein level of CYCD3 is induced in response to sucrose and hormones and form 
active CDKA/cyclin complex (Figure 1.1).  Furthermore, the enzymatic activity of CDKA/cyclin 
D is also regulated by being phosphorylated by CDKD/cyclin H complex.  The active 
CDKA/cyclin D complex then phosphorylate the Rb protein, preventing its association with the 
E2F transcription factor, thus allowing transcription of genes responsible for cell cycle 
progression.  In the process described above, CYCD3 appears to be the rate-limiting factor, as 
overexpression of this gene stimulates cells to exit the G1 phase (Nakagami et al. 2002).  
Conversely, CDK inhibitors or ICKs function to negatively regulate the cell cycle progression by 
inactivating the CDKA/cyclin D3 complex.  There is preliminary evidence to show that ICK2 
appears to be regulated by CDKB through a phosphorylation mechanism and targeted to the 
proteasome for protein degradation (Verkest et al. 2005).  Thus, the control of G1 to S cell cycle 
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progression involves a complex mix of positive and negative regulators, the expression of which 
are controlled spatially and temporally to ensure proper regulation of the cell cycle.   
  
 
Figure 1.1.  Model for the control of G1 to S transition in plants.  D-type cyclins (CYCDs) are 
induced by cytokinin and sucrose and form complexes with CDKA.  The CDKA/CYCD 
complex is further regulated positively by CAK phosphorylation and negatively by CDK 
inhibitors such as ICK1.  In the absence of a negative regulator, active CDKA/CYCD complex 
phosphorylates Rb protein, effectively dissociating Rb from the E2F transcription factor.  The 
unbound E2F becomes active and activates the transcription of various S-phase related genes 
required for cell cycle progression.  The above figure is taken from den Boer and Murray (2000).   
 
 
1.5 G2 to M transition 
In plants, both CDKA and CDKB appear to be important for the G2 to M transition by 
interacting with both A and B type cyclins.  CDKB probably regulates plant-specific features of 
cell cycle since no homologue of this gene is found in other species.  CDKA/B complexed with 
cyclin A/B is also regulated through phosphorylation by the CDKD/cyclin H complex as well as 
WEE1 kinase (Shimotohno et al. 2006).  WEE1 kinase phosphorylates CDKs on both Tyr15 and 
Thr14 residues to inhibit ATP fixation and blocks substrate binding.  CDKs phosphorylated at 
these residues are thus inactive.  A homolog to WEE1 has been characterized in maize and 
Arabidopsis (Sun et al. 1999; Sorrell et al. 2002).  In animals, a phosphatase CDC25 
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dephosphorylates the Tyr15 and Thr14 residues to activate the CDK/cyclin H complex.  In plants, 
a CDC25-like protein has been identified. However, it lacks a regulatory domain (Landrieu et al. 
2004) and its function as the typical CDC25 is questioned (Boudolf et al. 2006).  All together, a 
complicated network of interactions between multiple proteins is required to drive the cell to and 
through the mitotic divisions.   
 
1.6 Yeast two-hybrid system 
Specific interactions between proteins form the basis of many essential biological 
processes.  The yeast two-hybrid system, a technique that was developed in 1989, has 
revolutionarized how researchers study protein-protein interactions (Fields and Song 1989).  One 
advantage of using the yeast two-hybrid system is the ability to identify novel proteins that 
interact with a known, well-characterized protein (Hoppe-Seyler et al. 2001).  As well, this 
system can be used to study the interaction of known binding partners in detail, such as defining, 
by mutational analysis, the protein domains required for binding.  The premise behind the yeast 
two-hybrid system is that the domains of  transcription factors, DNA-activation and DNA-
binding domains, are modular and can function in close proximity to each other.  Thus, even 
when the DNA-activation and DNA-binding domains are split apart, they remain functional 
when brought together by two interacting proteins.  The protein of interest, ‘X’ is often fused to 
the DNA-binding domain (BD) and expressed as ‘bait’ in the yeast strain.  The other protein, ‘Y’ 
or a cDNA library is fused to the DNA-activation domain (AD) and referred to as the ‘prey’.  
Neither the bait nor the prey can activate transcription by itself.  However, if the bait and prey 
interact, the DNA-activation and DNA-binding domains are bridged together by the interacting 
proteins.  This transcription factor is reconstituted and thus able to activate the promoter of a 
marker gene which can be monitored by colorimetric assay or by growth selection.    
 
1.6.1 GAL4-based yeast two-hybrid system vs LexA-based yeast two-hybrid system 
Two most common yeast two-hybrid systems employ the yeast GAL4 or Escherichia coli 
(E. coli) LexA transcription factors.  Both two-hybrid systems function similarly in theory, with 
the main differences being the different activation domains, origins of replication, and reporter 
system used.  The GAL4-based yeast two-hybrid system uses both the DNA-binding domain and 
DNA-activation domain from the yeast GAL4 transcription factor.  The LexA yeast two-hybrid 
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uses the DNA-binding domain from the LexA protein and uses the activation domain from VP16, 
a herpes simplex virus protein or a weaker activation domain derived from bacteria, called B42.  
Different yeast two-hybrid vectors may have the ARS4/CENS origin of replication that has a low 
copy number in yeast, or the “2µ” origin of replication that has a relatively high copy number.  
Both systems use the lacZ reporter gene, which when activated, will turn the yeast colony into a 
blue color due to the cleavage of X-gal (5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside) 
by beta-galactosidase.  In addition, use of multiple reporter genes (i.e. nutrient marker like His-) 
help eliminate some of the false positives commonly observed with both yeast-two hybrid 
systems.  One of the advantages of using the LexA-based yeast two-hybrid system is that fusion 
proteins can be expressed inducibly under the control of the GAL1 promoter, allowing high 
levels of expression in the presence of galactose and repression in the presence of glucose.  This 
regulated expression allows rapid elimination of background colonies due to strain mutations.  
However, both systems have been proven to be successful in studying protein-protein 
interactions.   
 
1.6.2 Peptide aptamers 
Peptide aptamers represent a novel approach in identifying molecules which can disrupt 
protein-protein interactions in vivo (Geyer and Brent 2000).  Peptide aptamers are molecules in 
which a variable peptide with affinity for a target protein is displayed from a scaffold protein. 
They function under intracellular conditions and can block the function of the target proteins 
upon binding to them.  Peptides with randomized amino acids of 20 residues are synthesized and 
displayed in the active site of E. coli thioredoxin (TrxA).  The length of 20mer is an ideal size 
since it is long enough for the aptamers to fold into a diverse patterns of shape and charge, but 
short enough so that the number of stop codons introduced into the encoding oligonucleotides is 
not overwhelming.  Peptide aptamer libraries are screened against bait proteins using the LexA 
based yeast two-hybrid assay to select for aptamers that bind chosen baits.  Peptide aptamers that 
are selected to bind a target protein can be further analyzed for their ability to interfere with the 
functions of the target.  Thus, these aptamers can be used as trans-dominant agents to control and 
inhibit protein-protein interactions.  
It has been shown that peptide aptamers could disrupt the functions of a number of 
proteins, including two important cell cycle regulatiors: CDK2 and E2F (Colas et al. 1996; 
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Fabbrizio et al. 1999).  Peptide aptamers generated against CDK2 were able to interfere with 
CDK2-mediated phosphorylation of histone H1, but not with CDK2-mediated phosphoryation of 
pRb (Colas et al. 1996).  This is due to the non-overlapping regions on the CDK2 molecule for 
H1 and pRb interactions.  If the target protein has non-overlapping functional domains, peptide 
aptamers may inhibit one specific function of the protein without affecting the others depending 
on where the peptide aptamer binds.  This functional feature of peptide aptamers is very 
attractive, if it is desirable to block one specific function, but not other functions, of a target 
protein.   
  
1.7 Research objectives 
The research objectives for this master thesis are as follows: (1) Isolate and characterize 
peptide aptamers that interact with ICK1.  This project was conducted in collaboration with Dr. 
Ron Geyer.  (2) Identify regions of CYCD3 responsible for interacting with ICK1 using the yeast 
two-hybrid system.  (3) To determine the association and interaction of ICKs with the CDK 
complex in vivo and the effects of transgenic expression in plants.  (4) To determine whether 
ICKs are regulated by protein phosphorylation and further whether the protein level of ICKs is 
controlled through the ubiquitin-proteasome pathway.   
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CHAPTER 2: MATERIALS AND METHODS 
 
2.1 Bacterial transformation and plasmid isolation 
2.1.1 Plasmid isolation 
A 5 ml culture of bacterial cells was grown overnight at 37oC in LB medium containing 
an appropriate antibiotic (100 µg/ml ampicillin or 50 µg/ml kanamycin).  The next day, bacterial 
cells were collected by centrifugation and the pellet was re-suspended in 200 µl of solution 1 (25 
mM Tris-HCl (pH 9.0), 10 mM EDTA and 50 mM glucose).  The cells were then mixed with 
250 µl of solution 2 (0.2 N NaOH and 1% SDS) and following incubation on ice for 5 minutes, 
250 µl of solution 3 (3 M KOAc, pH 5.2) was added.  The solutions were mixed thoroughly and 
1/10th volume of 1 M MgCl2 was added. The cell lysate was incubated for 10 minutes at -20oC, 
and centrifuged. The upper liquid layer was transferred to a new 1.5 ml microtube. One volume 
of 2-propanol was added and the tube was incubated for 10 minutes at room temperature.  The 
tube was centrifuged and the pellet was washed with 70% ethanol.  The pellet was then air-dried 
and resuspended in 30 µl of H20 with 10 µg/ml RNAase.       
 
2.1.2 Bacterial transformation 
Competent E. coli DH10 cells for electro-transformation were prepared as described (Shi 
et al. 2003).  Plasmid DNA was added to 25 µl of competent cells and subjected to a high voltage 
charge of 1.6 kV using an electroporator (Eppendorf  Electroporator 2510).  Electroporated cells 
were collected with 1 ml of pre-chilled LB medium added to the cuvette immediately after the 
electroporation and incubated at 37oC for 1 hr without shaking.  Cells were plated onto LB plates 
containing an appropriate antibiotic (100 µg/ml ampicillin or 50 µg/ml kanamycin) and plates 
were incubated at 37oC overnight.    
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2.2 LexA-based yeast two-hybrid system 
2.2.1 Yeast manipulations  
YPD (yeast peptone dextrose: 1% yeast extract, 2% peptone and 2% glucose) was used as 
the medium for non-selective growth of yeast.  SD medium (synthetic dextrose: 0.67% yeast 
nitrogen base without amino acids and with addition of any necessary auxotrophic supplements 
at recommended concentrations) was used for selective growth of yeast auxotrophs.  Minimal 
dropout media are designated by the component that is left out (e.g. His-Trp-Leu- medium lacks 
histidine, tryptophan, and leucine).  Each minimal dropout medium contains either 2% glucose 
(Glu) or 2% galactose plus 1% sucrose (Gal/Suc).  X-Gal minimal drop-out plates contain X-gal 
and phosphate buffer at pH 7.0 (Geyer and Brent 2000).  Yeast cells were transformed by the 
modified lithium acetate method described by Elble (1992).  Yeast cultures were inoculated 
overnight at 30oC.  The following day, the 1 ml of cell cultures were spun down for 5 seconds.  
The supernatant was removed, leaving approximately 100 µl solution at the bottom of the tube 
with the cells.  Ten micrograms of carrier DNA, 0.5 µg of plasmid, 250 µl of PLATE mixture 
(sterile 45% PEG 4000, 1 M LiOAc, 1 M Tris-Cl (pH 7.5), 0.5 M EDTA) and 10 µl of 1.0 M 
DTT (dithiothreitol) were added to the cell suspension.  The cell culture was incubated at room 
temperature overnight and subjected to heat shock treatment (10 minutes at 42oC) the next day.  
Yeast cells were plated on appropriate amino acid dropout plates.  Yeast plasmid minipreps were 
prepared by the ‘smash and grab’ procedure of Hoffman and Winston (1987).  The E. coli strain 
MC1061 (Invitrogen) was used as competent cells for the transformation.   
  
2.2.2 Isolation of peptide aptamers 
The 20mer random peptide aptamer libraries used in this study were constructed in Dr. 
Ron Geyer’s laboratory as described (Geyer and Brent 2000).  Saccharomyces cerevisiae strains 
EGY48 (Matα his3 trp1 ura3-52 leu2::LexA6op-LEU2) and EGY42 (Mata his3 trp1 ura3 leu2) 
were used for the library screen.  The LexA fusion protein was expressed from the ADH1 
promoter on the bait expression vector pEG202 (Geyer and Brent 2000).  Aptamers fused to the 
B42 DNA-activation domain were conditionally expressed from the GAL1 promoter on the 
plasmid pJM-1 (Colas et al. 1996), a derivative of pJG4-4 (Gyuris et al. 1993).  The pJM-1-
derived peptide library in EGY42 were mated with the bait in EGY48.  The mated cells were 
plated onto YPD plates and incubated at 30oC for 3 days.  Yeast colonies were collected by 
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scraping the plates and the collected cells were stored at -80oC as frozen stock.  Aliquots of the 
frozen stock were plated onto Glu His-Trp- plates and grown at 30oC to select for colonies that 
contained both the bait and prey plasmids.  Colonies from these plates were replica-plated using 
sterile velvet onto Gal/Suc His-Trp-Leu-Ade- X-gal plates for determining reporter activity and 
visualization of interaction between the bait and prey (Geyer and Brent 2000).  The pJM-1 
plasmids containing the selected aptamers were recovered by selecting the yeast colonies and 
culturing them in SD Trp- medium.  The plasmids were isolated and used to transform the E. coli 
strain MC1061.  The recovered pJM-1 plasmids were re-transformed into the yeast strains 
containing the bait constructs to confirm interactions.     
   
2.3 GAL4-based yeast two-hybrid system 
2.3.1 Transfer of peptide aptamers and yeast two-hybrid analysis 
The yeast strain used for all GAL4-based yeast two-hybrid experiments was MaV203 
(Matα, leu2-3, 112, trp1-901, his3∆200, ade2-101, gal4∆, gal80∆, SPAL10::URA3, GAL1::lacZ, 
HIS3UASGAL1::HIS3@LYS2, can1R, cyh2R) (Vidal 1997; cell line was from GIBCO/BRL Life 
Technologies).  The DNA-binding domain vector (bait vector) was pDBLeu, a derivative of 
pPC62 (Chevray and Nathans 1992) and the DNA-activation domain vector (prey vector) used 
was pPC86 (both vectors were from GIBCO BRL/Life Technologies).  Primers were designed to 
amplify the 20 amino acid peptide aptamers from the pJM-1 plasmid and the PCR fragments 
were purified using the Qiagen PCR purification kit (Qiagen, Canada) according to the 
manufacturer’s instructions.  The recovered fragments were cloned into the bait vector pDBleu 
(and later into the prey vector pPC86 for domain swapping) and used to transform competent E. 
coli strain DH10 cells.  All clones were verified by PCR.  The constructs were used to transform 
MaV203 yeast strain carrying ICK1, cloned in the prey vector (bait vector for domain swapping).  
Interactions in the yeast two-hybrid system were analyzed by X-gal filter assay (Chevray and 
Nathans 1992).  Sterilized filter paper (Whatman) was used to lift yeast cells from plate and the 
filter was submerged in liquid nitrogen to permeabilize the cells.  The filter paper was then 
placed (cell side up) in a Petri dish covered with Z-buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 
10 mM KCl and 1 mM MgSO4) plus 2-mercaptoethanol (2.7 ml/L) and X-gal (50 mg/ml).  The 
plates were incubated at 30oC and checked at 2 hr and 24 hr for visualization of blue colonies.   
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2.3.2 Construction of CYCD3 deletion mutants and yeast two-hybrid analysis 
To analyze the interaction of Arabidopsis CYCD3;1 (referred to as CYCD3 hereafter; 
Soni et al. 1995), both the N and C-terminal deletion mutant constructs were prepared by PCR 
using Pfu DNA polymerase with sequence-specific primers (See Table 2.1).  The PCR fragments 
were amplified and cut with SalI and NotI and purified following agarose gel electrophoresis. 
The resulting DNA fragments were cloned into the bait vector pDBLeu (or into the prey vector 
for domain swapping).  The desired deletion clones were verified by PCR and DNA sequencing.  
The constructs were used to transform the yeast strain MaV203 harboring ICK1, cloned into the 
prey vector (bait vector for domain swapping) and grown on selective SD medium with the 
appropriate amino acids dropped out according to the manufacturer’s instructions (GIBCO 
BRL/Life Technologies).  Three or more independent transformants were tested for interactions 
for each construct using X-gal filter assay as described above. 
 
2.4 Construct preparation and plant transformation 
ICKs (ICK1 to ICK7) cDNAs were first cloned into the cloning vector pWZ851 (pZ31C) 
(Zhou et al. 2003b).  The BamHI-EcoRI fragments from pWZ851 were then cloned separately 
and linked transcriptionally behind the CaMV 35S promoter in the plant expression vector 
pBI121 (Clontech, USA).  For this study, the GFP-ICK1 construct was from Dr. Yongming Zhou; 
GFP-ICK2, GFP-ICK3, GFP-ICK6 and GFP-ICK7 constructs were prepared by Dr. Xianzong 
Shi; and GFP-ICK4 and GFP-ICK5 constructs were prepared by my self using the same cloning 
strategy.  The resulting plasmids were introduced into Agrobacterium tumefaciens strain 
GV3101 (An et al. 1998).   
Transformation of Arabidopsis thaliana ecotype Columbia was performed as described 
(Wang et al. 2000).  Plants were grown in 10-cm pots in a growth room (20-22oC constant 
temperature, 16/8 h (day/night) photoperiod).  Seeds (T1) from infiltrated plants were harvested 
and selected on half strength MS basal medium (Sigma-Aldrich) containing 50 mg/l kanamycin 
and 300 mg/l timentin (½ MSTK).  Seeds were sterilized in 20% bleach and 0.02% Triton X-100 
for 15 minutes and rinsed with sterile distilled H2O three times.  Kanamycin-resistant seedlings 
were transferred to soil in pots and grown in a growth room.  Seeds (T2) from selected lines were 
collected and used for subsequent experiments.            
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Table 2.1. Primers used for preparing Arabidopsis CYCD3 mutants.  
 
Name Sequence Used for 
   
#90 5’-CAGTGCGGCCGCTTTCGATTATGGAGTGGC N-terminal deletion mutants 
#206 5’-CAGTGTCGACAATGTCTTCTTCTTCTTCTCC ∆N42 mutant, with primer #90 
#207 5’-CAGTGTCGACAATGCTTTCCACGGATCGAAA ∆N82 mutant, with primer #90 
#208 5’-CAGTGTCGACAATGAGCTTACAGAGAGACAA ∆N122 mutant, with primer #90 
#209 5’-CAGTGTCGACAATGAAGTATGTGTTTGAAGC ∆N162 mutant, with primer #90 
#210 5’-CAGTGTCGACAATGGGACTTAAGAACAATGC ∆N202 mutant, with primer #90 
#89 5’-CAGTGTCGACAATGGCGATTCGGAAGG C-terminal deletion mutants 
#211 5’-CAGTGCGGCCGCTTAGTTTGAGCTTTCGTCGC ∆C49 mutant, with primer #89 
#212 5’-CAGTGCGGCCGCTTATAGTTGGAGGATTAGA ∆C94 mutant, with primer #89 
#213 5’-CAGTGCGGCCGCTTACATGGTAGCTGCCGC ∆C134 mutant, with primer #89 
#214 5’-CAGTGCGGCCGCTTATCTCCTGATAATGTGGTC ∆C175 mutant, with primer #89 
#401 5’-CAGTGCGGCCGCTTATGTCTCCTCCTCTTGAA ∆C214 mutant, with primer #89 
#402 5’-CAGTGCGGCCGCTTAGTAGCTACAGATGAACT ∆C254 mutant, with primer #89 
#403 5’-CAGTGCGGCCGCTTAATAAACATCATCGAGAC ∆C304 mutant, with primer #89 
#404 5’-CAGTGCGGCCGCTTACAAGGAAGAGTTTTCTT ∆C344 mutant, with primer #89 
 
 
 
2.5 Plant phenotype surveys 
Approximately 100 kanamycin-resistant plant seedlings for each construct growing on ½ 
MSTK plates for three weeks were transferred to soil (½ Sunshine mix and ½ ReadyEarth; 
purchased from Phytotron Plant Facilities, Agriculture Building, University of Saskatchewan).  
Plants freshly transferred to soil in 10-cm pots were covered with plastic lids to prevent plants 
from drying out.  The lid was gradually opened until it was completely removed after one week.  
The sizes and phenotypes of transgenic plants were surveyed in two weeks after the transfer to 
soil.  The diameter (the greatest width from leaf to leaf at the base) of the each plant was 
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measured.  Plants were surveyed for leaf serration and flower morphology.  Plants were 
categorized as having strong serrations if they had obvious and severe serrations in all of the 
leaves and were categorized as having moderate serrations if they had obvious but not severe 
serrations in most of the leaves.  For flower phenotype, plants were categorized as having strong 
flower abnormality if short pedicel, smaller petals and clustering of flower buds were observed.  
Plants were categorized as having moderate flower abnormality if moderate reduction in petal 
size and moderate clustering of flower buds were observed.      
 
2.6 Protein extraction and Western blotting analysis 
Protein samples were extracted from either seedlings or floral and leaf tissues of 3-4 
week old plants with the extraction buffer (25 mM Tris-HCl (pH 8.0), 100 mM NaCl, 5 mM NaF, 
1 mM Na3VO4, 1 mM beta-glycerophosphate, 2.5 mM EDTA and Sigma protease inhibitor 
cocktail (Sigma # P9599)) as described (Wang et al. 1998).  For Western blotting analysis of 
GFP fusion proteins, 25 µg of total protein was used for each sample and separated by standard 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE, 12% resolving gel). 
The SDS-PAGE sample buffer (6X buffer consisted of 0.25 M Tris-HCl pH 6.5, 15% SDS, 50% 
glycerol, 25% ß-mercaptoethanol, 0.01% bromophenol blue) was added to the protein sample, 
followed by heating at 95oC for 10 minutes.  The sample was used in electrophoresis.  Following 
electrophoresis, proteins were transferred onto a piece of PVDF membrane (Bio-Rad, USA) 
using Bio-Rad Mini-protein apparatus.  The blot was washed with distilled H2O briefly, then 
PBS buffer and blocked in 5% skimmed milk in PBS-T (PBS with 0.1% Tween 20) for either 1 h 
at room temperature or overnight at 4oC.  The membrane was probed for 1 hr with a monoclonal 
antibody against GFP (Clontech, USA; with a dilution of 1:3000) in PBS-T containing 2.5% 
skimmed milk and rinsed with PBS-T twice (5 minutes each).  The blot was then incubated with 
an anti-mouse horseradish (IgG) peroxidase conjugate (Bio-Rad; dilution 1:4000 in PBS-T 
containing 2.5% skimmed milk) for 1 hr and washed four times with PBS-T.  Probed proteins on 
blots were visualized using ECL Plus Western blotting detection reagents (Amersham Pharmacia 
Biotech) following the manufacturer’s instructions.   
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2.7 Affinity purification of proteins with p13Suc1-agarose beads. 
In all experiments involving proteins pulled down with p13Suc1-agarose beads, 200 µg of 
proteins were mixed with 6 µl suspension of p13Suc1-agarose beads.  The mixture in a tube was 
incubated, tumbling on a rotator at 4oC for 3 hrs followed by three washes with WB2 buffer (50 
mM Tris-HCL (pH 7.4), 250 mM NaCl, 0.1 % NP-40, 2.5 mM EDTA, and Sigma protease 
inhibitor cocktail).  The purified proteins were resolved by SDS-PAGE and subjected to Western 
detection using a GFP antibody as described above.      
 
2.8 Calf intestine phosphatase treatment of total proteins and proteins purified with 
p13Suc1-agarose beads 
For calf intestine phosphatase (CIP) treatments, 4 units or 20 units of CIP (New England 
Biolabs) or were used to treat 25 µg of total proteins or proteins affinity-purified with p13suc1-
agarose beads from 200 µg total proteins.  CIP treated samples were incubated at either 37oC 
(total proteins) or room temperature (protein samples pulled down with p13Suc1-agarose beads) 
for 20 minutes.  The enzymatic activity of CIP was halted by adding the SDS-PAGE sample 
buffer, and treated at 95oC for 10 minutes.  Samples were analyzed by Western detection as 
described above. 
 
2.9 Treatment of seedlings with proteasome inhibitor, MG132 
Twelve- to fourteen-day old T2 seedlings were treated with 100 µM of carbobenzoxyl-
leucinyl-leucinyl-leucinal (MG132) or equal volume of dimethyl sulfoxide (DMSO, control) 
dissolved in ½ MS media.  Seedlings were removed from incubation at 0, 4 and 8 hr, and used 
for protein extraction (Wang et al. 1998).  Proteins were extracted from the seedlings and 25 µg 
of protein was separated by SDS-PAGE and analyzed by Western blotting as described above. 
 
2.10 Bioinformatics analysis    
Primary sequences of ICKs were entered into three different internet based programs, 
Netphos1 (http://www.cbs.dtu.dk/services/NetPhosK/) , Netphos2 
(http://www.cbs.dtu.dk/services/NetPhos/) and Disphos (http://core.ist.temple.edu/pred/pred.html) 
to predict possible amino acid residues (serine, threonine and tyrosine) that can be 
phosphorylated (Blom et al. 1999; Iakoucheva et al. 2004).  Due to the vast amount of ‘hits’ for 
 24
each program, the stringency of each program was controlled.  For Netphos1, only residues that 
were predicted by the program to be phosphorylated by Cdc2 were included.  For Netphos2, an 
artificial neural network computation method is used to predict how likely a particular residue is 
phosphorylated (Blom et al. 1999). The score ranges from 0 to 1. The higher the score, the more 
likely a residue is phosphorylated. A cutoff value of 0.8 was used in this study. Disphos relies on 
position-specific amino acid frequencies and disorder information for the predictions 
(Iakoucheva et al. 2004).  The score generally approximates probability that the residue is 
phosphorylated. A cutoff value of 0.5 was used in this study. The amino acids that were 
predicted by all three programs were deemed the ‘consensus’ residues.  Only the results for 
serine and threonine residues predicted to be phosphorylated were presented in this study. 
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CHAPTER 3: ISOLATION OF PEPTIDE APTAMERS INTERACTING WITH ICK1 
AND CHARACTERIZATION USING TWO YEAST-TWO HYBRID SYSTEMS 
 
3.1 Results 
3.1.1 Isolation of peptide aptamers in a LexA-based yeast two-hybrid system 
The Arabidopsis CDK inhibitor ICK1 and ICK1109-191 (a truncated ICK1 containing a C-
terminal CDK inhibitory region conserved among ICKs) were used as the bait to screen two 
different peptide aptamer libraries.  Peptide aptamers were either fused to a scaffold protein, the 
Escherichia coli thioredoxin (E. coli TrxA) or an intein.  The intein library is a cyclic peptide 
yeast two-hybrid library with 7 amino acids designed by a graduate student, Kris Barreto in Dr. 
Ron Geyer’s lab.  A total of 6.5 x 108 and 1.0 x 107 yeast transformants for the E. coli TrxA and 
intein library respectively were screened by the LexA-based version of the yeast two-hybrid 
system.  The yeast transformants were plated onto Gal/Suc His-Trp-Leu-Ade- X-gal plates to 
allow selection and visualization of blue colonies that indicated an interaction between the bait 
(ICK1) and prey (peptide aptamers).  The color intensity of colonies on X-gal plates was rated 
(data not shown).  Since the color intensity is correlated to the strength of reporter gene 
expression, aptamers that had a stronger interaction with ICK1 would be expected to have a 
stronger color.  For the purpose of this study, only aptamers that have a strong interaction with 
ICK1 were selected.  To ensure that a single prey plasmid, not multiple prey plasmids, was 
responsible for the interaction with the bait, individual blue colonies were selected and cultured 
in SD Trp- media to select only for the prey plasmid.  To recover the plasmid, yeast DNA mini-
prep was obtained and used to transform E. coli cells (MC1061). Transformants were selected in 
LB medium containing ampicillin.  The plasmid was then purified using an alkaline mini-prep 
method and subsequently used to transform the yeast strain EGY48 carrying the bait plasmid.  
Transformants were plated onto Gal/Suc His-Trp-Leu-Ade- X-gal and if a single prey plasmid 
was responsible for interaction with the bait, all of the colonies on the plate should turn blue.  If 
the population of yeast transformants were not all blue, multiple prey plasmids were most likely 
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isolated in the initial screen, with one or more of the plasmids having no interaction with the bait.  
In such cases a single blue colony from the population was isolated and the verification process 
was repeated. In the end, 16 aptamers were isolated from the ICK1-TrxA screen (referred to as 
ICK1-TrxA aptamers), 8 aptamers from ICK1-Intein screen (ICK1-Intein aptamers), 17 aptamers 
from ICK1109-191-TrxA screen (ICK1109-191-TrxA aptamers) and 0 aptamers from ICK1109-191-
Intein screen. 
 
3.1.2 Characterization of peptide aptamers in a GAL4-based yeast two-hybrid system 
3.1.2.1 Analysis of interactions with the aptamers in the prey vector 
Peptide aptamers isolated from the LexA yeast two-hybrid screens were re-cloned into 
the GAL4-based yeast two-hybrid system for further characterization.  Aptamers were re-cloned 
into the DNA-binding domain vector, pDBleu (from now on referred to as the bait vector) and 
checked for interaction with ICK1 previously cloned in the activation-domain vector, pPC86 
(from now on referred to as the prey vector) in the yeast strain MaV203.  Yeast transformants 
were plated onto SD Trp-Leu- plates to select for the bait and prey plasmids.  Interactions 
between the aptamers and ICK1 were analyzed using the beta-galactosidase assay.  In this assay, 
if the aptamers and ICK1 interact with each other, the yeast colonies on the filter membrane will 
turn blue.  The level of reporter activity or the strength of the interaction was rated by observing 
the blue color intensity of the colonies.  Interestingly, not all of the aptamers that were positive in 
the LexA system in the initial screens were positive in the GAL4-based yeast two-hybrid.  As 
shown in Table 3.1, only 8 out of 16 ICK1-TrxA aptamers, 2 out of 17 ICK109-191-TrxA aptamers 
and 5 out of 8 ICK1-Intein aptamers showed varying levels of interactions.  Thus, interactions 
that were observed between the bait and prey in the system for isolating the aptamers might not 
show similar interactions in the GAL4-based yeast two-hybrid system. 
For the aptamers that showed an interaction with ICK1 in the GAL4-based yeast two-
hybrid system, further work was performed to determine whether these aptamers could interact 
with a truncated ICK1 containing a shorter C-terminal region important for the ICK1 interaction 
with CDK.  Aptamers in the bait vector were transformed into yeast cells containing ICK1137-191 
(an ICK1 deletion construct with 136 amino acid residues deleted from the N-terminus) in the 
prey vector or the prey vector alone.  Interactions between aptamers and ICK1137-191 were 
analyzed once again by beta-galactosidase assay.  In terms of interaction with ICK1137-191, 7 of 8 
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ICK1-TrxA, 1 of 2 ICK1109-191-TrxA and 5 of ICK1-Intein aptamers showed varying degrees of 
reporter activities (Table 3.2).  However, many of them also showed reporter activity with the 
prey vector alone, indicating that some of the aptamers, when they are fused with the GAL4 
DNA-binding domain, could activate the lacZ gene without interacting with ICK1. Of all the 
aptamers tested in this experiment, only 3 of the ICK1-TrxA aptamers showed interactions with 
both versions of ICK1 (full length and ICK1137-191) without activating the lacZ reporter gene on 
their own (Table 3.2).  However, it should be noted that for most of the aptamers, the intensity of 
the color or strength of reporter activity with the vector alone was considerably less than the 
intensity observed for interactions with ICK1 or ICK1137-191. 
 
 
 
Table 3.1.  Initial analysis of interactions between aptamers and ICK1 in a GAL4-based yeast 
two-hybrid system. Aptamers isolated from a LexA-based yeast two-hybrid system were re-
tested in a GAL4-based system.    
 
Aptamers Number of 
aptamers 
tested 
Interaction 
with ICK1
Strong 
Interaction 
****/***** 
Medium 
Interaction 
*** 
Weak Interaction 
**/* 
ICK1 TrxA 16 8 3 3 2 
ICK1109-191 TrxA 17 2 0 1 1 
ICK1 Intein 8 5 4 0 1 
Total 37 15 7 4 4 
(1) Strength of interactions between aptamers and ICK1 was determined by observing the 
intensity of the colonies’ color ranging from strong (*****) to weak (*).   
(2) To ensure that the beta-galactosidase filter assay worked, a positive control (a yeast 
transformant with CYCD3-ICK1 interaction) was plated along with the aptamers.  After two 
hours the intensity of the positive control was rated as (**), and after 24 hours the intensity was 
rated as (*****).     
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Table 3.2.  The analysis of interactions between selected aptamers and ICK1 or ICK1137-191 in a 
GAL4-based yeast two-hybrid system   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aptamers Control 
(pPC86) 
ICKI full length  ICK1137-191  
ICK1109-191 
TrxA 
2 hr 24 hr 2 hr 24 hr 2 hr 24 hr 
21.2 / / / ** / * 
       
ICKI TrxA 2 hr 24 hr 2 hr 24 hr 2 hr 24 hr 
12.1 * *** *** **** ** ***** 
38.1 * *** ** **** ** ***** 
49.3 / / / *** / *** 
32.1 / / / *** / ** 
35.4 / * / *** / *** 
8.2 / * / **** * **** 
38.3 / / / ** / ** 
       
ICKI Intein 2 hr 24 hr 2 hr 24 hr 2 hr 24 hr 
20.1 / ** * **** / ** 
13.1 * *** *** ***** / ** 
11.2 * *** ** **** / * 
19.1 / * / ** / * 
12.1 ** *** ** ***** * **** 
 
 (1) To ensure that the beta-galactosidase filter assay worked, a positive control (a yeast 
transformant with CYCD3-ICK1 interaction) was plated along with the aptamers.  After two 
hours the intensity of the positive control was rated as (**), and after 24 hours the intensity was 
rated as (*****).     
 
 
 
Eight aptamers (6 ICK1-TrxA, 1 ICK1109-191-TrxA, and 1 ICK1-Intein) that showed an 
interaction with both ICK1 and ICK1137-191, but not with or less with the prey vector pPC86 
alone were further selected to test for their interactions with other members of the ICK families.  
As summarized in Table 3.3, most of the eight aptamers showed interactions with several ICKs.    
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Table 3.3.  The analysis of interactions between selected aptamers and ICKs in a GAL4-based 
yeast two-hybrid system 
 
 Control 
(pPC86) 
 ICKI full 
length 
ICK1137-191 ICK2 ICK3 
Aptamers 2 hr 24 hr 2 hr 24 hr 2 hr 24 hr 2 hr 24 hr 2 hr 24h 
Control (pLeu) / / / / / / / / / / 
ICK1109-191 
TrxA 
          
21-2 / / / ** / * / / / / 
ICK1 TrxA           
12-1 * *** *** **** ** ***** ** *** ** *** 
49-3 / / / *** / *** / ** / * 
32-1 / / / *** / ** / ** / * 
35-4 / * / *** / *** * *** / * 
8-2 / * / **** * **** * ** / ** 
38-3 / / / ** / ** / * / ** 
ICK1 Intein 2 hr 24 hr 2 hr 24 hr 2 hr 24 hr 2 hr 24 hr 2 hr 24h 
12-1 ** *** ** ***** * **** *** ***** *** ***** 
 
 
Table 3.3.  (continued)   
 ICK4 ICK5 ICK6 ICK7 
Aptamers 2 hr 24 hr 2 hr 24 hr 2 hr 24 hr 2 hr 24 hr 
Control (pLeu) / / / / / / / / 
ICKBD TrxA         
21-2 / / / / / / / / 
ICK1 TrxA         
12-1 ** ** * ** ** *** / * 
49-3 / * / / / * / / 
32-1 / ** / * / * / / 
35-4 / ** / * * * / / 
8-2 * ** * ** * ** / * 
38-3 / ** / * / * / / 
ICK1 Intein 2 hr 24 hr 2 hr 24 hr 2 hr 24 hr 2 hr 24 hr 
12-1 ** ***** * ***** ** ***** / **** 
 
(1) To ensure that the beta-galactosidase filter assay worked, a positive control (a yeast 
transformant with CYCD3-ICK1 interaction) was plated along with the aptamers.  After two 
hours the intensity of the positive control was rated as (**), and after 24 hours the intensity was 
rated as (*****).     
 
 
 
 30
3.1.2.2 Analysis of interactions with the aptamers in the bait vector 
Since some peptide aptamers when fused with the GAL4 DNA-binding domain in the 
bait vector could activate reporter activity with the empty prey vector, we wanted to know (1) 
whether swapping the bait and prey into the ‘opposite’ vector could eliminate this self activation 
and (2) whether aptamers still retain the interaction with ICKs when they are expressed from the 
prey vector.  The aptamers were re-cloned into the prey vector while ICK1 was cloned into the 
bait vector.  The presence of the cloned fragment for both the aptamers and ICK1 was verified by 
PCR.  Analyses of interactions between aptamers and ICK1 in this context were measured using 
beta-galactosidase filter assay on yeast transformants.  Surprisingly, none of the peptide aptamers 
in the prey vector retained its interaction with ICK1.   
To clarify the issue regarding why interactions between aptamers and ICK1 were 
observed in one context, but not in the other, the aptamers in the initial LexA-based prey vector 
(pJG4-5) were used to determine their interactions with ICK1 in the GAL4-based bait vector.  
Since the DNA-binding domain of GAL4 and activation domain of LexA are expected to 
function modularly, I determined whether the aptamers in a LexA-based prey (activation-domain) 
vector could interact with ICK1 in a GAL4-based bait (binding-domain) vector.  Yeast 
transformants were plated onto SD Trp-Leu- plate and three independent colonies were streaked 
onto a Gal/Suc Trp-Leu- plate.  Galactose was used to activate the GAL1 promoter of the 
aptamer plasmid.  Interactions between the aptamers and ICK1 were determined using the beta-
galactosidase filter assay.  Seven out of the eight aptamers showed no interaction with ICK1 in 
this test.  One of the aptamers (one of three independent colonies) showed an interaction with 
ICK1. 
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3.2  Discussion    
Peptide aptamers have been shown to be able to bind to specific proteins and be used as 
transdominant agents to control and inhibit protein-protein interactions (Colas et al. 1996; 
Fabbrizio et al. 1999; Butz et al. 2001; Xu and Zhijun 2002; Schmidt et al. 2002).  Due to its 
simplistic nature and effectiveness in affecting protein-protein interactions in vivo, they have 
been used for studying the biochemical pathways within living cells and also considered as 
possibly useful tools for drug therapy (reviewed by Crawford et al. 2003).  As peptide aptamers 
are becoming an increasingly popular technique to study protein-protein interactions, we would 
like to use peptide aptamers to study the role of ICKs in plants.  Our goal was to (1) isolate 
aptamers that are able to interact with ICK1 and (2) express these aptamers in plants to modulate 
the protein-protein interactions and to assess the effects of the aptamer on plants.   
A total of forty-one aptamers were initially isolated with a LexA-based yeast-two hybrid 
system.  Selected aptamers were re-cloned into a different system for further analyses mainly due 
to the following two reasons. (1) The family of ICK proteins has been studied in a GAL4-based 
yeast two-hybrid system. The aptamers with the scaffold protein thus need to be expressed in a 
compatible vector with the ICKs. (2) The interaction of these aptamers needed to be verified. 
Since the subsequent objective is to express them in plants, it is beneficial to verify the 
interaction when the aptamers are expressed in a slightly different cellular context. If the 
interaction is not retained in a different yeast two-hybrid system, it is not very likely that the 
interaction will be retained when the aptamer is expressed in the plant.   
Of the forty-one aptamers isolated initially from the screens in the LexA-based yeast two-
hybrid system, only fifteen of them showed an interaction with ICK1 after the aptamers were 
cloned into the GAL4-based yeast-two hybrid bait vector.  The observed difference in terms of 
the aptamer interaction with ICK1 between the system used for isolating the aptamers and the 
system for characterizing the interaction can be due to several technical differences between the 
two systems e.g. different origins of replication for the plasmids, and different activation 
domains used for the two-hybrid interaction. Generally speaking, the LexA system used for 
aptamer isolation is more sensitive, but gives rise to higher backgrounds, than the GAL4 system 
used in this study.  More sensitivity could allow the identification of weaker interacting aptamers. 
Thus, interactions that were observed between the bait and prey in the system for isolating the 
aptamers might not show an interaction in the GAL4-based yeast two-hybrid system. 
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In the GAL4-based yeast two-hybrid system, eight aptamers that were in the bait vector 
showed an interaction with ICK1.  However, they did not show an interaction with ICK1 when 
they were expressed in the prey vector.  There may be several possible reasons for this 
observation.  One possible reason could be that the interactions between ICK1 and the aptamers 
in the GAL4-based yeast two-hybrid system are also context-dependent.  Swapping the bait and 
prey might have altered the context within which an interaction between the bait and prey 
occurred initially. Similarly, the observation that no interactions were observed between 
aptamers in the LexA-based prey vector and ICK1 in the GAL4-based bait vector also indicates 
that the bait and prey interactions are affected by the proteins with which they are fused. To 
ensure that the negative interaction observed in the GAL4-based system was not due to the 
conformation change of ICK1 cloned in the bait vector, CYCD3, a known interacting partner of 
ICK1 (Wang et al.1998), was cloned into the prey vector and tested for interaction with ICK1.  A 
strong interaction between CYCD3 and ICK1 in this context was observed, indicating that ICK1 
cloned in the bait vector likely folded correctly and was properly targeted to the nucleus.   
 Another possible reason could be that weak interactions might not be detected due to the 
low levels of fusion proteins in the GAL4-based system. The plasmids of the LexA-based yeast 
two-hybrid system used in the present study contain the 2µ origin of replication, while the 
plasmids of the GAL4-based system use CEN6 origin of replication (Chevray and Nathans 1992). 
Since the 2µ plasmids usually have much higher copy numbers in yeast than the CEN-based 
plasmids (Gerbaud and Guerineau 1980; Bonneaud et al. 1991), the protein levels produced from 
CEN-based plasmids are expected to be lower. Thus, two proteins that show a weak interaction 
in the LexA-based system used may not show an interaction when tested in the GAL4-based 
system.  In addition, the binding affinity of the GAL4 and LexA binding domains to DNA may 
also be different, contributing to the differences observed between the two systems.    
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CHAPTER 4: IDENTIFICATION OF REGIONS IN CYCD3 INTERACTING WITH 
ICK1 
 
4.1 Results 
4.1.1 Interactions between CYCD3 deletion mutants in bait vector and ICK1 in prey vector 
Since the approach to isolate aptamers able to interact with ICK1 produced only limited 
results, and D-type cyclins all interact with ICK1, it was decided that it would be interesting and 
fitting to identify regions or motifs in CYCD3 responsible for interacting with ICK1.  To that 
end, a series of deletion mutants were prepared and cloned into the GAL4-based bait vector 
pDBLeu.  In total, five CYCD3 N-terminal deletion mutants (∆N42, ∆N82, ∆N122, ∆N162, and 
∆N202 with the number following the letter “N” indicating the number of amino acid residues 
deleted from the N-terminus) and eight CYCD3 C-terminal deletion mutants (∆C49, ∆C94, 
∆C134, ∆C175, ∆C214, ∆C254, ∆C304, ∆C344) were prepared. The deletion mutants were 
designed so that sequence fragments of similar lengths (40-50 amino acid residues) were 
removed stepwise from either the N-terminus or C-terminus. These constructs were confirmed 
by DNA sequencing and used for determining the interaction with ICK1 in the prey vector.  The 
full length CYCD3 (376 amino acids) was used as a positive control.  As shown in Table 4.1, full 
length CYCD3 was able to interact with ICK1, which resulted in a strong activity of the reporter 
beta-galactosidase.  Interestingly, deletion of 42 amino acids in the N-terminal region of CYCD3 
abolished most of the ability of CYCD3 to interact with ICK1.  Further deletion (i.e. deletion of 
N-terminal 82 residues) completely abolished CYCD3 interaction with ICK1.  For the C-
terminal deletion mutants, deletion of 49 and 94 amino acids from the C-terminal region of 
CYCD3 resulted in a weaker interaction with ICK1 compared to the full-length CYCD3 (Table 
4.1).  Surprisingly, ∆C175 showed a weak interaction with ICK1 while ∆C134 did not show an 
interaction with ICK1.  To confirm this observation, this experiment was repeated and similar 
results were observed.  Furthermore, ∆C304 also showed an interaction with ICK1 (Table 4.1). 
However, this interaction appeared to be false, since ∆C304 could activate the reporter with the 
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prey vector pPC86 alone.  All other deletion mutants that are not mentioned above showed no 
interaction with ICK1 (Table 4.1).  
 
 
Table 4.1.  Determination of interactions between CYCD3 deletion mutants in the bait vector 
pDBLeu and ICK1 in the prey vector pPC86 
 
 pPC86 
(prey vector) 
ICK1 
pLeu (bait vector)  / / 
CYCD3 full length / **** 
∆N42 / * 
∆N82 / / 
∆N122 / / 
∆N162 / / 
∆N202 / / 
∆C49 / * 
∆C94  / ** 
∆C134  / / 
∆C175 / ** 
∆C214 / / 
∆C254 / / 
∆C304  **** **** 
∆C344  / / 
 
Number of (*) denotes the strength of interaction as indicated by the blue color intensity 
observed in the beta-galactosidase assay, with (****) representing a strong interaction and (/) 
representing no interaction. 
 
 
4.1.2 Interactions between CYCD3 deletion mutants in prey vector and ICK1 in bait vector 
To verify the results observed on the interactions of CYCD3 deletion mutants with ICK1, 
the fusion proteins were swapped between the bait and prey vectors so that the CYCD3 deletion 
mutants were in the prey vector pPC86 while ICK1 was in the bait vector pDBLeu.  The full-
length CYCD3 in the prey vector was used as a positive control and showed a strong interaction 
with ICK1 in the bait vector (Table 4.2).  In contrast to previous observations that ∆N42 deletion 
mutant showed a weak interaction with ICK1, none of the N-terminal deletion mutants showed 
an interaction with ICK1 in this context.  As for the C-terminal deletion mutants, the ∆C49 and 
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∆94 deletion mutants in the prey vector, as in the bait vector, still showed an interaction with 
ICK1 (Table 4.2).  In contrast, the ∆C175 and ∆C304 deletion mutants in the prey vector showed 
no interaction with ICK1.   
 
 
Table 4.2.  Determination of interactions between CYCD3 deletion mutants in the prey vector 
pPC86 and ICK1 in the bait vector pDBLeu 
 
 pDBLeu 
(bait vector) 
ICK1 
pPC86 (prey vector)  / / 
CYCD3 full length / **** 
∆N42 / / 
∆N82 / / 
∆N122 / / 
∆N162 / / 
∆N202 / / 
∆C49 / *** 
∆C94  / *** 
∆C134  / / 
∆C175 / / 
∆C214 / / 
∆C254 / / 
∆C304  / / 
∆C344  / / 
 
Number of (*) denotes the strength of interaction as indicated by the blue color intensity 
observed in the beta-galactosidase assay. With (****) representing strong interaction and (/) 
representing no interaction.   
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4.2 Discussion 
ICK1 has been shown to interact with both CYCD3 and CDKA;1  (Wang et al. 1998). 
However, the regions in both CYCD3 and CDKA;1 responsible for interacting with ICK1 remain 
to be identified. Interestingly, ICK1 overexpression in Arabidopsis plants leads to an increase in 
transcript levels of CYCD2 and CYCD3, indicating a possible feedback regulation system (Zhou 
et al. 2003a).  It is believed that cell division and phenotype of plants depends on the interactions 
of different positive (i.e. CYCD3) and negative regulators (i.e. ICK1) of CDKs.  A series of 
CYCD3 deletion constructs were prepared and the interactions of these CYCD3 deletion mutants 
with ICK1 were analyzed using the GAL4-based yeast two-hybrid system along with beta-
galactosidase filter assay.  
To analyze the interaction between CYCD3 and ICK1, CYCD3 deletion mutants were 
cloned into the bait vector pDBLeu and ICK1 into the prey vector pPC86.  To confirm the results 
observed in this combination, the fusion proteins were swapped to the opposite vectors and again 
tested for yeast two-hybrid interactions. In contrast to what was observed for ICK1, the results 
from a series of deletion mutants of CYCD3 suggest that both the N-terminal and C-terminal 
regions of CYCD3 are needed for CYCD3 to interact with ICK1 in the yeast two-hybrid system, 
although a slightly longer C-terminal region appears to be dispensable.  
There are two possibilities for this observation. Firstly, the residues involved in the 
interaction of CYCD3 with ICK1 may be scattered in the linear sequence but are brought 
together when the protein is folded so that deletion of either the C-terminal or the N-terminal 
region demolishes the interaction. Secondly, the protein expression level or structural stability 
may be affected by the deletions.  In this regard, it is worth noting that CYCD3 (with 376 amino 
acids) is a highly unstable protein (Planchais et al. 2004).  The primary sequence of CYCD3 
suggests that the protein possess two PEST sequences that may confer instability to the protein 
(Soni et al. 1995).  One of the PEST sequences is located in the N-terminal region (amino acid 
28-69) of the protein, while the other is located in the C-terminal (302-351).  In the deletion 
mutants of CYCD3 (∆N42, ∆C49, ∆C94), one of the PEST sequences was removed or partially 
removed. In these mutants, the ability for interacting with ICK1 was retained. The inability of 
other mutants, with further deletions to interact with ICK1, could not be attributed to the removal 
of the PEST sequences, since if the PEST sequences are functional, their removal would increase 
the accumulation of the mutant proteins.   
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The primary sequence of CYCD3 also has a region of amino acids (86-191) designated as 
the cyclin box which appears to be evolutionarily conserved among diverse species (Soni et al. 
1995).  The cyclin box is the region responsible for binding with CDKs.  Thus, it is more likely 
that the inability of the CYCD3 mutants with a deletion beyond the N-terminal 42 amino acids or 
C-terminal 94 amino acids to interact with ICK1 is due to possible alterations of structures 
required for the interaction.  This suggestion could be further determined by analyzing the 
protein expression levels of the various deletion mutants.  However, based on the above rationale 
and considering that we could not map the sequence in CYCD3 responsible for interacting with 
ICK1 to a narrow region, we decided not to proceed with the work of determining protein levels.  
Instead, I proceeded with the work described in the next two chapters.   
Different results were observed for the ∆C175 deletion mutant.  When it was in the prey 
vector, ∆C175 showed an interaction with ICK1, but it did not show such an interaction when it 
was in the bait vector.  Both experiments (with ∆C175 mutant and ICK1 in opposite vectors) 
were performed twice and the results were consistent.  It is possible that the ∆C175 deletion 
mutant could activate the reporter expression when fused with the GAL4 DNA-binding domain.  
However, in this case, the activation of reporter should also be expected when the ∆C175 
deletion mutant was expressed with the vector alone, but it was not observed.  It is also possible 
that the interaction of the ∆C175 deletion mutant might be more sensitive to the context change 
(switching from the prey vector to the bait vector) than the full-length protein.  Thus, it remains 
to be further clarified whether ∆C175 deletion mutant could interact with ICK1.     
The ∆C304 deletion mutant in the bait vector could activate reporter activity with the 
prey vector alone. However, it could not activate the reporter expression when expressed in the 
prey vector which contains a GAL4 DNA-activation domain, suggesting that the ∆C304 mutant 
might function as a transcription activation domain when fused with the DNA binding domain in 
the bait vector in the yeast two-hybrid system. This observation is surprising and interesting, 
indicating that this CYCD3 deletion mutant could function as a transcription-activating domain.  
However, the observation that the full-length CYCD3 showed little activity of transcription 
activation suggests that the strong activity of transcription activation for the truncated CYCD3 
may more likely be incidental rather than a biologically relevant function of CYCD3.  
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CHAPTER 5: STUDIES OF ICK PROTEIN EXPRESSION, INTERACTION WITH 
CDK/CYCLIN COMPLEX, AND STABILITY IN TRANSGENIC PLANTS 
 
5.1 Results 
5.1.1 Plant transformation and phenotypic effects of ICK expression 
Previous studies have shown that transgenic overexpression of ICK1, ICK2, ICK4, 
NtKIS1a (a tobacco ICK-related gene), and ICKCr (a Chenopodium rubrum ICK-related CDK 
inhibitor) results in changes to plant growth and morphology (Wang et al. 2000; De Veylder et al. 
2001; Jasinski et al. 2002b; Zhou et al. 2002a).  These transgenic plants are often smaller in size, 
and have serrated leaves and altered flower morphology compared to wild type plants (Wang et 
al. 2000).  However, the phenotypic effects from overexpression of other ICKs (ICK3, ICK5, 
ICK6 and ICK7) are not known and it will be interesting to see whether those ICKs exert similar 
phenotypic effects on transgenic plants.  A number of independent transgenic plants were 
obtained with each of the ICK constructs (ICK1 to ICK7 linked to GFP) plus the GFP control.  
The 35S promoter was used to drive the expression of the respective gene.  A survey of the GFP-
ICK and control (GFP-only) transgenic plants on the size of seedlings, leaf serrations and flower 
morphology was conducted.  Transgenic GFP-ICK plants showed a greater variation in terms of 
size, likely due to various levels of GFP-ICK expression.  The diameter (the span from rosette 
leaf to rosette leaf) of each transgenic plant was measured in two weeks after transfer and the 
average for each construct was obtained.  The averages for the seven GFP-ICK constructs ranged 
from 32.7 mm to 55.0 mm and were all lower than the average for the control GFP construct 
(61.1 mm).  The trend for GFP-ICK plants to be smaller than the control GFP plants was clear, 
although the size varied from plant to plant.  The inhibition of plant growth, defined simply as 
reduction in the physical size of plants, could be better observed in the progeny plants of the 
GFP-ICK lines when they were compared to the GFP control plants under identical conditions 
(Figure 5.1).  These results provide evidence that similar to ICK1, ICK2 and ICK4 reported 
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previously, overexpression of ICK3, ICK5, ICK6 and ICK7 are all capable of inhibiting growth 
of transgenic Arabidopsis plants.  
Some transgenic plants (Table 5.1) showed the typical phenotype of serrated leaves for 
all ICKs (Figure 5.2).  The percentages of transgenic plants showing moderate and strong 
serrations were obtained from the survey for each ICK construct (Table 5.1).  Since weak 
serrations were occasionally observed for GFP-control transgenic lines, only moderate and 
strongly serrated leafs were considered to be true phenotypic effects of ICK overexpression.  The 
percentages of plants with moderate to strong leaf serrations were comparable for GFP-ICK1 
(7.5%), GFP-ICK2 (9.8%), GFP-ICK3 (10.3%), GFP-ICK6 (10.2%) and GFP-ICK7 (9.7%) 
(Table 5.1).  The percentages were lower for GFP-ICK4 (3.1%) and GFP-ICK5 (4.4%).  For the 
GFP control, no plant with moderate to strong serrations of leaves was observed.  Furthermore, 
there were differences in terms of the extent of leaf serrations among different ICKs.  Strongly 
serrated leaves were observed in the transgenic plants of GFP-ICK1, GFP-ICK2, GFP-ICK5, 
GFP-ICK6, and GFP-ICK7, but not in GFP-ICK3 and GFP-ICK4 plants (Table 5.1; Figure 5.2).  
Since the survey was based on 59-104 independent transformants for each construct, these results 
suggest that although all ICK members are capable of causing phenotypic changes to the leaves 
of transgenic plants, some ICK members may be stronger inhibitors and can cause stronger 
phenotypic changes than others.           
The flower morphology of the transgenic plants was also surveyed.  Again, guidelines 
were established to aid the categorization of the degree of flower abnormality.  Transgenic lines 
displaying shorter pedicel, smaller petals and compact inflorescence are categorized as having a 
strong phenotype.  Transgenic lines displaying intermediate clustering of inflorescence and 
reduction in petal size are categorized as having a moderate phenotype.  Similar to the leaf 
serration phenotype, strong changes in floral morphology were only observed in transgenic 
plants of GFP-ICK1, GFP-ICK2, GFP-ICK5, GFP-ICK6 and GFP-ICK7, not in the plants of 
GFP-ICK3 and GFP-ICK4.   
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Table 5.1  Phenotypic effects of overexpressing GFP or GFP-ICKs on transgenic Arabidopsis 
plants.    
 
Number of 
plants 
transferred 
and survived 
Percentage (%) of 
plants with leaf 
serrations 
Percentage (%) of 
plants with changes in 
flower morphology 
 
Trans. Surv. Moderate Strong Total Moderate Strong Total 
GFP 100 92 0.0 0.0 0.0 0.0 0.0 0 
GFP-ICK1 112 94 1.1 6.4 7.5 8.5 3.2 11.7 
GFP-ICK2 110 102 4.9 4.9 9.8 2.0 3.9 5.9 
GFP-ICK3 88 78 10.3 0.0 10.3 3.8 0.0 3.8 
GFP-ICK4 101 98 3.1 0.0 3.1 5.1 0.0 5.1 
GFP-ICK5 108 92 1.1 3.3 4.4 4.3 2.2 6.5 
GFP-ICK6 100 59 3.4 6.8 10.2 1.7 6.8 8.5 
GFP-ICK7 120 104 1.0 8.7 9.7 3.8 5.8 9.6 
   
Primary transformants (T1) were selected on Petri plates and after three weeks transferred to soil 
in pots.   Two weeks after the transfer, a survey of the GFP and GFP-ICK transgenic plants 
measuring size of seedlings, leaf serrations and flower abnormality were performed.  Leaf 
serration of transgenic plants were categorized as either strong (strong leaf serrations in all leaves) 
or moderate (obvious but not severe serrations in majority of leaves).  Surveys were conducted at 
3- and 4-weeks after the transfer on flower morphology. Transgenic plants were categorized as 
either strong (shorter pedicel, smaller petals and strong clustering of floral buds) or moderate 
(with moderate changes).   
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Figure 5.1. Phenotypes of transgenic GFP-ICK plants. (a) Seedlings were grown in soil and 
pictures were taken when plants was 23 days old. The top four pots from left to right are: GFP, 
GFP-ICK1, GFP-ICK2 and GFP-ICK3. The bottom four pots from left to right are: GFP-ICK4, 
GFP-ICK5, GFP-ICK6 and GFP-ICK7.  (b) Representative plants were removed from pots and 
being photographed together so that the relative plant size could be better compared. Plants from 
left to right: GFP, GFP-ICK1, GFP-ICK2, GFP-ICK3, GFP-ICK4, GFP-ICK5, GFP-ICK6, GFP-
ICK7.   
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Figure 5.2. Individual transgenic plants. GFP (a), GFP-ICK1 (b), GFP-ICK2 (c), GFP-ICK3 (d), 
GFP-ICK4 (e), GFP-ICK5 (f), GFP-ICK6 (g) and GFP-ICK7 (h). Note serrated leaves with 
transgenic GFP-ICK plants.  
 
 
5.1.2 Expression of GFP-ICK fusion proteins in transgenic Arabidopsis plants 
Since ICKs were expressed as GFP-fusion proteins, Western blotting using an anti-GFP 
antibody provided a good way to determine the presence and level of fusion protein in transgenic 
plants.  Preliminary analysis revealed that GFP-ICK1 recombinant proteins were expressed at a 
low level in general, consistent with the observation on GFP-ICK1 (Zhou et al. 2003b).  Thus, 
only transgenic plants with strongest phenotypes (leaf serrations and modified flowers) along 
with control plants were used to determine presence of the fusion proteins.   Three independent 
lines for each GFP-ICK construct and one proven transgenic line for the GFP control were 
selected for the analysis.   
Results are shown in Figure 5.3.  Fusion proteins were detected in at least one line for 
each of the GFP-ICK constructs at around the 62 kDa mark except for the GFP-ICK3 construct.  
For the GFP-control transgenic line, no fusion protein is detected, however a high level of GFP 
with a molecular weight of 28 kDa was detected in the Western blot.  For GFP-ICK1, GFP-ICK2 
and GFP-ICK5, fusion proteins were detectable for all three transgenic lines tested (Figure 5.3).  
For GFP-ICK3, no fusion protein was detected for the three transgenic lines tested.  
(a) (b) c (d)
(e) (f) (g) (h)
(c)
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Subsequently, several other transgenic lines of GFP-ICK3 were also tested and again none 
showed a detectable level of the fusion protein.    For GFP-ICK4, GFP-ICK6 and GFP-ICK7, 
only one out of three transgenic lines tested showed a detectable level of fusion protein.  Thus, 
despite the generally low level of expression, fusion proteins were detected in at least one line 
for each construct.   
 
 
 
 
Figure 5.3. Western analysis of GFP and GFP-ICK fusion proteins in transgenic Arabidopsis 
plants.  Three independent lines for each GFP-ICK construct were selected and protein samples 
were extracted from the floral buds and the leaves.  For each sample, 25 µg of protein for each 
sample were separated by SDS-PAGE and analyzed on a Western blot.  The type of transgenic 
plant is indicated above the lane. A non-specific band was observed for all transgenic lines at 
around 45 kDa.  
  
 
5.1.3 Effects of a proteasome inhibitor, MG132 
The mammalian CDK inhibitor p27Kip1 has been shown to be targeted for degradation 
through the proteasome upon phosphorylation by CDK2 (Vlach et al. 1997). A recent study 
shows that ICK2 protein can be phosphorylated by Arabidopsis CDKB in vitro and ICK2 protein 
level increases in the cdkb mutant plant (Verkest et al. 2005).  To determine whether ICKs are 
degraded through the proteasome pathway in vivo, a proteasome inhibitor MG132 was used to 
treat transgenic GFP-ICK as well as GFP plants.  Twelve to fourteen day-old seedlings for each 
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ICK construct were treated with either 100 µM MG132 (a peptide proteasome inhibitor) or an 
equal volume of DMSO (control).  For GFP-ICK1, GFP-ICK5, GFP-ICK6 and GFP-ICK7, the 
results were consistent showing an increase in protein level following MG132 treatments (Figure 
5.4). For GFP-ICK2 and GFP-ICK4, no clear increase was observed under the conditions used, 
indicated that MG132 had no effect.    
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 (b)                  GFP-ICK1 (a)                    GFP 
  MG132      0hr     4hr-    4hr+    8hr-   8hr+   MG132      0hr     4hr-    4hr+    8hr-   8hr+ 
α-GFP α-GFP 
α-Tub α-Tub 
(d)                  GFP-ICK4 (c)                  GFP-ICK2 
  MG132      0hr     4hr-    4hr+    8hr-   8hr+   MG132      0hr     4hr-    4hr+    8hr-   8hr+ 
α-GFP α-GFP 
α-Tub α-Tub 
(e)                  GFP-ICK5 (f)                  GFP-ICK6 
  MG132      0hr     4hr-    4hr+    8hr-   8hr+   MG132      0hr     4hr-    4hr+    8hr-   8hr+ 
α-GFP α-GFP 
α-Tub α-Tub 
(g)                  GFP-ICK7 
  MG132      0hr     4hr-    4hr+    8hr-   8hr+ 
α-GFP 
α-Tub 
 
 
Figure 5.4. Effect of MG132 treatments on the accumulation of GFP-ICKs in transgenic plants. 
Twelve to fourteen day-old seedlings were subjected to the treatment of either 100 µM MG132 
or equal volume of DMSO (control) for up to 8 hrs.  Seedlings were removed from the treatment 
at specific time points (0, 4 or 8 hrs) and proteins extracted. Twenty five micrograms of proteins 
were resolved on SDS-PAGE and Western blot analysis was performed using an anti-GFP 
antibody.  Blots were stripped and re-probed with an antibody against tubulin as a loading 
control.  (a) GFP, (b) GFP-ICK1, (c) GFP-ICK2, (d) GFP-ICK4, (e) GFP-ICK5, (f) GFP-ICK6 
and (g) GFP-ICK7.   
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5.2 Discussion 
Previous studies have demonstrated that overexpression of ICK1, ICK2 and ICK4 in 
plants results in inhibition of growth, leaf serrations and modifications of flower morphology 
(Wang et al. 2000; De Veylder et al. 2001; Zhou et al. 2002a).  The present results indicate that 
all ICKs exert similar phenotypic effects on Arabidopsis plants, although the extent of the 
phenotypic effect appears different among members of the ICK family.  This study shows that all 
ICK members, to a varying degree, are capable of inhibiting the growth of plants.   
For all ICK constructs, the frequency of plants showing clear leaf serrations and changes 
in flower morphology was low. There are two major reasons for this observation. First, the 
morphological changes were only observed in plants where the cell division and cell number 
were reduced to a great extent (Wang et al. 2000). Second, GFP-ICK fusion proteins were only 
detected in a small proportion of transgenic plants, indicating that ICKs were expressed in 
general at a low level. Thus, only when the ICK1 fusion protein is expressed at a sufficient level, 
do plants show the morphological changes. 
The study further shows that only moderate leaf serration and floral changes were 
observed for ICK3 and ICK4 transgenic lines, while the other ICKs had at least one or more lines 
from 59-104 primary transformants displaying strongly serrated leafs and floral changes.  The 
observation on the frequency and severity of the phenotype in the independent transformants 
(Table 5.1) indicates that ICK3 and ICK4 have a weaker phenotypic effect on Arabidopsis than 
other ICK members.  One explanation for the differences in phenotypic effect observed between 
different ICKs may be related to the ability of ICK to interact with cyclin and CDKA.  A 
previous study had shown that overexpression of ICK1 has greater phenotypic effects on 
transgenic plants than ICK4 (Zhou et al. 2002a).  It was suggested that the stronger effect for 
ICK1 may be due to the ability of ICK1 to interact with both D-type cyclins and CDKA while 
ICK4 can only interact with D-type cyclins, making ICK1 a more potent inhibitor.  Consistent 
with the suggestion, ICK3 has also been shown to be unable to interact with CDKA (De Veylder 
et al. 2001).  Thus, the differences in inhibition strength between different ICKs may depend on 
their ability to interact with CDKA.  The ICK members that are able to interact with both CDKA 
and cyclins appear to have the greater phenotypic effects on transgenic plants.   
Alternatively, the weaker phenotypic effects by ICK3 and ICK4 could be due to lower 
levels of protein accumulation in plant cells.  It has been shown that when the level of ICK1 
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increases, the phenotypic effect in Arabidopsis plants is stronger (Zhou et al. 2003b). Since the 
strongest three independent lines for each GFP-ICK construct were selected from 80-100 
transformants, they could be considered to represent the group of high expressors for a particular 
GFP-ICK construct.  Also, since the non-specific band (Figure 5.3) was much more similar 
among different samples, most of the differences in the level of fusion proteins could not be 
attributed to the variation in the amount of protein loaded in the gel.  Instead, most of the 
differences should be attributed to the differences in the level of fusion proteins expressed in the 
plants.  The results indicate that GFP-ICK3 was expressed at the lowest level among all ICKs, 
while GFP-ICK4 was also at a relatively low level.  Taken together, both a lower level of protein 
and the lack of interaction with CDKA may contribute to the weaker phenotypic effect exhibited 
by ICK3 and ICK4.    
The control of protein abundance in a cell is essential to ensure proper functioning of all 
cellular processes.  Environmental or intracellular cues perceived by cells may lead to more 
synthesis or degradation of a particular protein, to maintain an appropriate protein level. In the 
present study, the expression of GFP-ICK constructs was driven by the 35S promoter, which is a 
strong and widely used promoter.  Despite this strong promoter, GFP-ICK fusion proteins were 
only detected in a small proportion of transgenic plants.  The transgenic lines used for analyzing 
protein expression were selected from 80 to 100 independent transformants for each construct 
based on their phenotypes (Table 5.1), although a few lines for some constructs could not 
produce seeds due to the severity of the phenotype.  The observations that only a low level of 
fusion protein was observed for all ICKs and in the case of ICK3 no fusion protein was detected 
clearly indicates that the fusion proteins for all ICKs were expressed at a low level.  This low 
level of protein expression should not be due to the GFP protein used for the protein fusion. First, 
the 35S-GFP plants showed a very high level of GFP protein.  Second, in GFP-ICK plants a 
large amount of degraded fusion protein at various sizes and particularly at the size to GFP 
protein alone were observed (Figure 5.3).  Thus, the low levels of GFP-ICK proteins are likely 
due to the inherent instability of ICK proteins.   
There are two main mechanisms by which proteins are degraded in cells, the proteolytic 
enzymes within the lysosome and the ubiquitin-proteasome pathway (review by Myung et al. 
2001).  Many cell cycle regulators, including A, B and D-type cyclins as well as CDKB are 
degraded by the 26S proteasome, which is mediated by protein ubiquitylation (Genscik et al. 
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1998; Planchais et al. 2004, Weingartner et al. 2003).  The mammalian CDK inhibitor p27Kip1 is 
shown to be degraded by the proteasome upon phosphorylation on the Thr187 residue (Vlach et 
al. 1997).  A recent study has also provided preliminary evidence that the plant CDK inhibitor 
ICK2 may be targeted for degradation through the ubiquitin-proteasome pathway (Verkest et al. 
2005).  Thus, we are interested in finding out whether all other ICKs are subjected to degradation 
through the ubiquitin-proteasome pathway in vivo.       
The mode of degradation for ICK in vivo was addressed in this study by using a 
proteasome inhibitor MG132 to inhibit the function of the 26S proteasome.  If the ICK proteins 
are degraded by the proteasome, the fusion protein level of transgenic plants will be expected to 
accumulate to a higher level in the presence of MG132 than the control.  As shown in Figure 5.4, 
the level of fusion protein when treated with MG132 was noticeably higher for GFP-ICK1, GFP-
ICK5, GFP-ICK6 and GFP-ICK7 compared to the control at both the 4-hr and 8-hr time points, 
indicating the involvement of proteasome in the degradation of these ICK proteins.  However, no 
clear effect by MG132 was observed on the protein level of GFP-ICK2 and GFP-ICK4, 
suggesting that the proteasome may not play a significant role in the degradation of those two 
proteins.  In Western blotting experiments, variation among samples could be introduced due to 
several factors including protein concentration determination and sample loading.  Precautions 
were taken to ensure that an observed effect was reproducible.  For instance, to ensure the 
differences in fusion protein level observed was not due to unequal amount of protein loaded, the 
PVDF blots were stripped and re-probed with an antibody against tubulin. The experiments were 
repeated two to three times independently. Taking the possible loading variation into 
consideration, the results suggest that, if there is an effect, the effect on ICK2 and ICK4 by 
MG132 would be less compared to other ICKs.  
The observation that MG132 treatment did not have an effect on the stability of ICK2 
protein is different from that observed by Verkest et al. (2005).  The specific reason for this 
difference is yet to be determined.  One possible reason might be seedling age. While 5-day old 
seedlings were used in the study by Verkest et al. (2005), 14-day old seedlings were used in the 
present study.  Other experimental conditions might also be responsible for the difference.  
However, since all treatments were performed under the same conditions in this study, the 
present results indicate that the proteasome affects the degradation of some ICKs more than 
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others.  A clear effect was observed for ICK1, ICK5, ICK6 and ICK7, but not for ICK2 and 
ICK4.   
 Although an effect on protein accumulation by MG132 treatment was observed for ICK1, 
the increase was modest.  In contrast, a great amount of change in protein level was observed 
when the N-terminal region of ICK1 was removed (Zhou et al. 2003b).  The regulation through 
ubiquitin-mediated pathway implicated by the effect of MG132 treatment may contribute to the 
increased protein stability after the N-terminal removal. However the mild increase following 
MG132 treatment may be difficult to explain all the change in protein level after the removal of 
N-terminal region.  Further work is needed to determine whether another mechanism exists that 
regulates the stability of ICK1 as well as other ICKs.  In this regard, Jakoby et al. (2006) 
observed that MG132 treatment also resulted in the accumulation of ICK1109-191, consistent with 
the suggestion that more than one mechanism may be involved in regulating the stability of 
ICK1. 
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CHAPTER 6: PHOSPHORYLATION STUDIES OF ICKS IN TRANSGENIC 
ARABIDOPSIS PLANTS 
 
6.1 Results 
6.1.1 Analysis of putative phosphorylation sites in ICKs  
Since post-transcriptional modifications such as phosphorylation can critically affect 
protein-protein interactions and other protein functions, we were interested in determining 
whether ICKs undergo phosphorylation.  Bioinformatics analysis was performed to obtain 
information on putative phosphorylation sites in ICKs.  The primary sequences of ICKs were 
inputted into Netphos1, Netphos2 and Disphos (Blom et al. 1999; Iakoucheva et al. 2004).  Both 
Netphos2 and Disphos are bioinformatics programs that predict potential phosphorylation sites 
on serine, threonine and tyrosine residues while Netphos1 predicts possible phosphorylation sites 
by Cdc2 (a yeast homologue of CDK).  The stringency of the software was controlled to limit the 
number of hits.  For example, in the case of Netphos2, a score of >0.8 was needed in order for 
the residue to be considered a ‘hit’.  Even with such stringency, each software still produced 
numerous hits of possible phosphorylated residues.  Thus, only the residues that were a hit with 
all three softwares were counted as the ‘consensus’ residues for the purpose of this study.  Since 
CDKs are known serine/threonine kinases and ICKs are most likely phosphorylated by them, I 
used the number of serine/threonine residues that were predicted to be potential phosphorylated 
sites as an indicator for how likely an ICK protein is phosphorylated.   
As shown in Table 6.1, no residues were predicted to be phosphorylated for ICK1, ICK2 
and ICK3.  Three residues were predicted to be phosphorylated for ICK4, seven residues for 
ICK5, three residues for ICK6 and four residues for ICK7.  These predictions were similar to 
those predicted by Wang et al. (2007) who predict the residues of ICKs that can be 
phosphorylated by CDKA based on the motif sequence [TS]-P-x-[RKQSL].  Using this approach, 
no residues are predicted for ICK1, ICK2 and ICK3, while three residues for ICK4, two residues 
for ICK5, one residue for ICK6 and four residues for ICK7 are predicted.   
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 Table 6.1.  Analysis of potential phosphorylation sites in ICKs using three programs   
 
Predicted potential serine/threonine residues Protein 
Netphos1 Netphos2 Disphos Consensus 
ICK1 4 11 6 0 
ICK2 2 13 20 0 
ICK3 4 13 6 0 
ICK4 6 21 17 3 
ICK5 12 29 30 7 
ICK6 7 19 10 3 
ICK7 8 26 15 4 
 
Number of potential phosphorylation sites of serine/threonine in ICKs predicted using 
bioinformatics programs Netphos1, Netphos2 and Disphos.  The score of >0.8 and >0.5 is 
required for residues to be counted as a possible phosphorylation site for Netphos2 and Disphos 
respectively.  Residues that are predicted to be phosphorylated by all three programs are grouped 
under ‘consensus’.      
 
 
6.1.2 Determining the conditions for using CIP to study phosphorylation of ICKs 
One technique to study the phosphorylation status of ICKs is to treat proteins or protein 
extracts with CIP.  CIP is a phosphatase that can remove 5’ phosphate groups from DNA, RNA, 
nucleotides and proteins.  To determine whether CIP is a useful tool to study the phosphorylation 
status of ICKs, GFP-ICK1 total protein extracts were treated with increasing amount of CIP and 
for the control samples without CIP.  The samples were subjected to electrophoresis and Western 
blotting analysis. As shown in Figure 6.1a, the GFP-ICK1 fusion protein band showed a gradual 
downward shift with increasing amount of CIP added, indicating that the molecular weight was 
decreasing with increased amount of CIP.  CIP treatment appears to specifically affect GFP-
ICK1 since no ‘shift’ is observed for the non-specific band in the gel.  CIP was also used to treat 
the proteins pulled down using the p13Suc1 –conjugated agarose beads.  As shown in Figure 6.1b, 
GFP-ICK1 proteins of CIP-treated samples showed a downward shift compared to the non-CIP 
treated samples.  This observation confirms the feasibility of using CIP to study phosphorylation 
state of ICK1 and provides evidence that at least a proportion of ICK1 is phosphorylated in the 
cell and can be dephosphorylated.     
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(a) (b) 
 GFP
 
  
Figure 6.1. Test of CIP treatments for detecting phosphorylated GFP-ICK1 in total protein 
extract and CDK complex. (a) Effect on GFP-ICK1 in total protein extract. Twenty five 
micrograms of total protein extract from GFP-ICK1 were treated with increase amount (units) of 
CIP as indicated for 20 minutes. The same amount of total protein from GFP plant was also 
loaded as the control. The samples were analyzed by Western detection using an antibody to 
GFP. (b) Effect on GFP-ICK1 in the CDK complex pulled down with p13Suc1-conjugated 
agarose beads. A total of 200 µg protein extract from GFP-ICK1 plants was used in the protein 
pulldown and the pulldown proteins were treated with 0, 0.3 and 2 units of CIP as indicated for 
20 minutes. Twenty five micrograms of total protein (first lane) were also used as a reference. 
Western detection was performed as in (a). 
 
 
6.1.3 Effect of CIP treatment on ICKs 
Since the initial experiments with GFP-ICK1 showed that CIP could be used to treat the 
total protein extract and the GFP-ICK1 fusion protein showed increased migration in the gel, the 
effect of CIP treatment on other GFP-ICK proteins was determined similarly.  One transgenic 
line for each of the GFP-ICK constructs (with the exception of GFP-ICK3) that showed a 
detectable level of fusion protein under the current conditions was used and the total protein 
extract was treated with CIP.  CIP-treated samples and non-CIP-treated samples were compared 
on Western blot to determine whether a change in the migration of the fusion protein occurred.  
Samples treated with CIP showed a clear downward shift (increased migration) for GFP-ICK1, 
GFP-ICK2, GFP-ICK5, and GFP-ICK6 compared to their non-CIP treated counterparts (Figure 
6.2).  The CIP treated GFP-ICK4 sample did not show a clear shift compared to the non-treated 
sample.  Comparison of the migration rate between the CIP-treated GFP-ICK7 and non-CIP-
treated GFP-ICK7 could not be done since the CIP-treated GFP-ICK7 fusion protein band 
disappeared on the Western blot.  The increased migration by CIP treatment was specific only to 
                 GFP-ICK1              _   Pulldown _ Total  
CIP (U)             0     0.1    0.3    1.0    3.0   10 CIP (U)           0    0.3  2.0 
Fusion  Fusion protein protein
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several GFP-ICK fusion proteins and was not observed for the GFP and other protein bands 
(Figure 6.2), suggesting that the effect of CIP treatment could not be due to non-specific protein 
degradation.  More likely, this increased migration of the GFP-ICK fusion proteins is due to 
dephosphorylation by CIP treatment. These results indicate that ICK1, ICK2, ICK5 and ICK6 
undergo phosphorylation in plant cells. 
 
 
 
  
 
Figure 6.2.  Effects of CIP treatment on GFP-ICK fusion proteins extracted from transgenic 
plants. Total protein extract (25 µg for each sample) from one line for each of the GFP-ICK 
constructs was treated with 2.5 units of CIP or water for control for 30 minutes.  The CIP-treated 
(indicated by “+” sign) and untreated samples (indicated by “-” sign) were run on a SDS-PAGE 
gel and analyzed by Western blotting.  The type of transgenic plant is indicated above the lane. 
 
 
 
The above observation suggests that GFP-ICK7 is less stable following the CIP-treatment.  
To confirm this observation, a time course experiment was conducted to compare the stability of 
GFP-ICK1 and GFP-ICK7.  The total protein extracts were treated with CIP and removed at 0, 
10, 20 and 30 minutes.  The samples were subject to Western analysis. For both GFP-ICK1 and 
GFP-ICK7, as observed previously, a shift in fusion protein band position was detected in CIP-
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treated samples compared to the non-CIP-treated samples (Figure 6.3).  Further, the level of 
fusion protein gradually decreased with the increasing time of CIP treatment.  Interestingly, this 
decrease in the amount of fusion protein was more evident for GFP-ICK7 than for GFP-ICK1 
(Figure 6.3), indicating that GFP-ICK7 is less stable following CIP treatment.    
 
 
Min 
 
 79  
 47  
 33  
 24  
 
 
Figure 6.3.  A time course experiment of CIP treatment on GFP-ICK1 and GFP-ICK7 
Total protein extracts of GFP-ICK1 and GFP-ICK7 were treated with CIP at 37oC.  Samples 
were removed at specific time points (0, 10, 20 and 30 min) and 25 µg of each sample were 
loaded onto a SDS-PAGE, followed by Western blotting.   
 
 
 
6.1.4   Interaction of ICKs with CDK/Cyclin complex in vivo and effect of CIP treatment on 
ICKs associated with the complex  
The association of the inhibitors with CDK complex in vivo was demonstrated only for 
ICK1 (Zhou et al. 2003b) and ICK2 (Verkest et al. 2005).  It is interesting to determine whether 
other ICK members also interact with the CDK complex in vivo.  In this experiment, one 
transgenic line for each of the GFP-ICK construct (with the exception of GFP-ICK3) that has 
shown a detectable level of fusion protein was used and CDK complex of associated proteins 
were pulled down with p13Suc1-conjugated agarose beads.  The p13Suc1 beads can bind to the 
CDK complex of eukaryotic species (De Veylder et al. 1997; Pines 1996) and thus pull down 
proteins associated with the CDK complex.  If ICK is able to interact with the CDK complex, it 
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will be pulled down along with the CDK/cyclin complex by the p13suc1 beads.  The fusion 
protein can then be detected by Western blotting using anti-GFP antibody.  As shown in the 
Western blot in Figure 6.4, fusion proteins pulled down with p13Suc1 beads were detected for 
each of the ICK construct except for the GFP control and GFP-ICK7.  Fusion proteins for GFP-
ICK1, GFP-ICK2, GFP-ICK4, GFP-ICK5 and GFP-ICK6 were all detected.  Unfortunately, 
several GFP-ICK7 primary transformants with a strong phenotype did not produce seeds and 
among the GFP-ICK7 lines obtained, only one line showed sufficient GFP-ICK7 protein for this 
type of experiments.  Thus we were not able to use another line to test whether ICK7 is able to 
interact with the CDK complex in vivo.  Nevertheless, the present results suggest that among the 
six ICKs examined, five are shown to be able to interact with the CDK complex in vivo, with 
ICK7 to be further determined. 
To determine whether ICKs bound with the CDK complex are also phosphorylated, the 
p13Suc1-affinity purified proteins, instead of total proteins, were treated with CIP and subjected to 
Western analysis.  The fusion proteins of GFP-ICK1, GFP-ICK2, GFP-ICK5, and GFP-ICK6 
treated with CIP showed a clear shift compared to non-CIP-treated proteins (Figure 6.4).  This 
observation is consistent with the results on the effect of CIP treatment on total protein extract.  
For GFP-ICK4, the CIP-treated fusion protein appeared to migrate faster.  However, the fusion 
protein for both the CIP-treated and non-CIP-treated samples showed smearing and a doublet 
band (Figure 6.4). The observed smearing of the fusion protein and diffused bands suggest either 
that GFP-ICK4 fusion protein is prone to degradation or that some of GFP-ICK4 fusion protein 
may also be in phosphorylated form.  As for GFP-ICK7, no fusion protein was detected in the 
CIP treated and non-CIP-treated samples.   
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Figure 6.4. Western analysis of GFP-ICK fusion protein pulled down with p13suc1-agarose 
conjugate beads with CIP treatment. For each sample, 200 µg of proteins from seedlings was 
used for affinity purification with p13Suc1-conjugated agarose beads and then treated with CIP or 
for control without CIP.  Samples were resolved by SDS-PAGE, following by Western analysis. 
Samples for non-CIP treated (indicated by a “-” sign) and CIP treated (indicated by a “+” sign) 
were loaded side by side to detect possible band shift on the Western blot.  (a) and (b) are images 
of the same gel at different exposure times: 5 minutes (a) and 1 minute (b). With the shorter 
exposure, the shifts for GFP-ICK1, GFP-ICK2 and GFP-ICK6 can be better seen.  
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6.2 Discussion 
 Phosphorylation is one of the most fundamental mechanisms in eukaryotes to modify 
proteins, through which their functional activities, abundance and cellular localization can be 
regulated.  Since mammalian and yeast CDK inhibitors have been shown to undergo 
phosphorylation (Vlach et al. 1997; Tomoda et al. 1999), it is our interest to see whether plant 
CDK inhibitors also possess this mode of regulation.  The putative phosphorylation sites of 
serine and threonine residues were predicted using three software programs.  The sites predicted 
by Netphos2 program were too numerous and difficult to interpret. The Netphos1 and Disphos 
software programs predict some sites on all ICKs.  The results from CIP treatment experiments 
however show that ICK1, ICK2, ICK5, and ICK6 are likely more phosphorylated than ICK4.  
This profile is not consistent with profiles predicted by the Netphos1 and Disphos programs or 
with the “consensus” profile generated by the three prediction software programs.  Thus, for the 
plant CDK inhibitors, the putative phosphorylation sites predicted by the current software 
programs should not be viewed as the true phosphorylation sites or an indication for the extent of 
phosphorylation of ICKs.  Actual experimental work is required to determine the 
phosphorylation status of ICKs.  
To test whether ICKs undergo phosphorylation in vivo, an alkaline phosphatase CIP was 
used to treat protein samples extracted from 10 to 14 day old seedlings.  Since CIP has been 
shown to be capable of effectively releasing phosphate groups from phosphorylated tyrosine, 
serine and threonine residues in proteins, it has been used by researchers to study the 
phosphorylation state of proteins (Su et al. 2006).  Phosphorylated proteins often display a 
downward shift in band positions after CIP treatment on the gel compared to untreated proteins.  
One possible reason for this observation may be that CIP treatment of a protein dephosphorylates 
it, making it less bulky and lower mass compared to the phosphorylated form.  As a result the 
dephosphorylated form travels faster in the SDS-PAGE gel.  Another reason for the observed 
differences in mobility may be due to the changes in protein structure after CIP treatment. The 
application of SDS theoretically eliminates and linearizes the secondary and tertiary structures of 
a protein. However, the secondary structures may not be completely disrupted by SDS treatment. 
Dephosphorylation of the protein by CIP treatment may result in a conformation change and a 
faster migration on the SDS-PAGE gel.  It has been shown that phosphorylation may make a 
protein longer and more rigid (Hagestedt et al. 1989). 
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 In this experiment, when total protein extracts or proteins affinity-purified with p13Suc1-
beads (containing CDK complexes) were treated with CIP, GFP-ICK1, GFP-ICK2, GFP-ICK5, 
and GFP-ICK6 fusion proteins all showed a migratory shift on the Western blot.  This result 
provides the first evidence that ICK1, ICK2, ICK5 and ICK6 proteins can be dephosphorylated 
in vivo.  The observation that no shift is detected for the non-specific bands indicates that the 
migratory shift observed for the fusion protein was not due to protein degradation or a non-
specific effect.  The data also suggest that perhaps not all ICK members undergo the same level 
of phosphorylation in plants.  GFP-ICK4, compared to other GFP-ICKs showed no shift 
following CIP treatment in the case of total protein extract and showed a not very visible shift in 
the case of protein sample affinity-purified with p13suc1-beads.  Thus more work is needed to 
clarify whether ICK4 undergoes phosphorylation in vivo.   
 The degree of shift from non-CIP treated samples to CIP treated samples also appear to 
differ among ICKs members, although it was difficult to objectively quantify the amount of shift 
observed. Since protein with more phosphorylation sites will be expected to show a greater shift 
than proteins with fewer phosphorylation sites after being subjected to CIP treatment, the greater 
shift may be indicative of multiple phosphorylation sites in these proteins.  In this study, GFP 
was used to aid the detection of ICKs, since the expression system for the fusion proteins and 
detection techniques were proven to be working in the laboratory. The migration shift of the ICK 
proteins following CIP treatments may be better studied when they are tagged with a short 
epitope tag.  
 Another possible approach to study protein phosphorylation is to use Pro-Q 
phosphoprotein reagent (Invitrogen) that is said to bind the phosphate groups in phosphoproteins, 
allowing in-gel visualization of phosphoproteins.  Pro-Q staining was thus tested using total 
protein extracts and proteins purified with p13Suc1-conjugated beads.  In the case of total proteins, 
many bands appeared on the gel after staining. With p13Suc1 affinity-purified proteins, only very 
faint bands could be observed, indicating that the amount of proteins was too low for good 
visualization using this method.  Further optimization may be needed.  
It was observed that the fusion protein of GFP-ICK7 was present in the non-CIP-treated 
sample, but was absent in the CIP-treated sample (Figure 6.2).  The possibility that the GFP-
ICK7 band in the CIP-treated sample was not transferred properly from the SDS-PAGE gel to 
the nitrocellulose membrane was low since other bands in the lane were transferred and evident.  
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The amount of protein loaded, as judged by the non-specific band was also similar between the 
CIP treated and non-CIP treated samples.   A more likely and attractive explanation for the 
absence of the fusion protein band is that the dephosphorylated form of GFP-ICK7 is less stable 
than the phosphorylated form.  In a time course experiment in which the total protein extract was 
treated with CIP for different lengths of time, it was revealed that the longer the protein extract 
was treated with CIP, the less abundant of fusion protein was detected on the Western blot 
(Figure 6.3).  This decrease in protein level was more drastic for GFP-ICK7 than for GFP-ICK1.  
These results suggest that dephosphorylation of ICK7 protein by CIP treatment renders the 
protein less stable.  It is known that mammalian and yeast CDK inhibitors are targeted for 
degradation after being phosphorylated by CDKs (Vlach et al.1997; Tomoda et al. 1999).  The 
present results indicate that the stability of at least one member of the ICK family may also be 
subject to regulation by protein phosphorylation.  It will be interesting to verify this observation 
and determine how phosphorylation may affect the stability of ICK7.  
Yeast two-hybrid analyses have revealed that there are likely two groups of plant CDK 
inhibitors.  The A-group inhibitors ICK1, ICK2, ICK6 and ICK7 interact with CDKA;1 and 
three D-type cyclins (D1, D2, D3), while the B-group inhibitors ICK4, ICK5 and ICKCr interact 
with D-type cyclins but not with Arabidopsis CDKA;1 (Zhou et al. 2002a).  Thus far, only ICK1 
and ICK2 have been shown to be able to interact with the CDK complex in vivo.  The present 
results confirm the previous observation that ICK1 and ICK2 are able to interact with the CDK 
complex in vivo (Wang et al. 2000; De Veylder et al. 2001).  These results also show that ICK4, 
ICK5 and ICK6 are able to interact with the CDK complex in vivo.  As for ICK7, it is surprising 
that no GFP-ICK7 was pulled down by p13Suc1-affinity pull down assay.  Considering that ICK7 
can interact with both CDKA;1 and D-type cyclins in the yeast two-hybrid system, this lack of 
binding to the CDK complex may not be due to a lack of interaction, but more likely due to a 
low level of stability and rapid degradation of ICK7 in vivo and also during the assay.  This 
suggestion is supported by the observation that fusion protein of GFP-ICK7 was comparably less 
stable than other GFP-ICK proteins.  
The results from CIP treatment of p13Suc1-affinity purified proteins further show that 
some proteins of ICK1, ICK2, ICK5, and ICK6 associated with CDK complexes are 
phosphorylated.  This observation suggests that these ICKs when phosphorylated can still 
interact with the CDK complex.  For GFP-ICK4, the observed smearing of the fusion protein and 
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diffused bands suggest either that GFP-ICK4 fusion protein is prone to degradation or that GFP-
ICK fusion protein exists in phosphorylated and dephosphorylated forms.  Due to the apparent 
instability, this observation requires further investigation.   
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CHAPTER 7: GENERAL DISCUSSION, CONCLUDING REMARKS AND FUTURE 
DIRECTIONS 
 
In all eukaryotes, the cell cycle is controlled by the CDK/cyclin complex and thus also by 
the positive and negative regulators of the CDK/cyclin complex.  CDK inhibitors can bind and 
inhibit the activities of CDKs.  In plants, a family of CDK inhibitors (referred to as ICKs or 
KRPs) has been identified.  Since the plant CDK inhibitors are very different from the 
mammalian CDK inhibitors, understanding the functions and regulation of the plant CDK 
inhibitors could provide new insight on the molecular mechanisms regulating the cell cycle in 
plants and the differences between plants and animals.  Since the initial discovery in 1997, 
substantial progress has been made on many aspects of plant CDK inhibitors particularly with 
ICK1, including the expression, protein-protein interactions, cellular localization, role in cell 
division and endoreduplication, and effect on plant growth (Wang et al. 2006).  
Despite the progress, there are still many questions about the plant CDK inhibitors as 
they are related to the cell cycle directly as well as to other processes in plants. In Arabidopsis, 
the ICK family has seven members.  One general question is why Arabidopsis needs seven CDK 
inhibitors and what the differences are among different CDK inhibitors.  A fuller understanding 
to this question will undoubtedly be achieved from studies examining various aspects of the ICK 
expression, function and regulation. To that end, this thesis project attempted to investigate 
mainly two aspects of ICKs: their interactions with other proteins and their posttranslational 
modification by phosphorylation.  
All of the seven Arabidopsis ICKs can interact with D-type cyclins.  Preliminary 
evidence indicates that the majority of them can also interact with CDKA, while ICK4 and ICK5 
may not interact with CDKA.  It is important to understand the basis for ICK interactions with 
CDKA and D-type cyclins and functional roles for the interactions. Since peptide aptamers have 
been shown to be able to bind known proteins and used as trans-dominant agents to perturb 
protein-protein interactions, we attempted first to isolate peptide aptamers that could interact 
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with ICKs, particularly with the conserved CDK inhibitory region.  If such an aptamer could be 
obtained, we could express it with a scaffold protein in plants to disrupt the protein-protein 
interaction between ICKs and CDKA, and to study the biological effect.  Following the initial 
screen, a set of aptamers were obtained.  After subjecting to vigorous tests in two yeast two-
hybrid systems, we did not obtain an aptamer that possesses a strong interaction with ICKs in 
both systems.  
Following the protein-protein interaction theme, work was then performed to analyze the 
interaction between D-type cyclins and ICKs.  We felt that it might be possible to identify a 
region in Arabidopsis CYCD3 and further specific motifs or amino acid residues responsible for 
the interaction.  However, results from this study show that removal of a relatively short region 
from either the N-terminal or the C-terminal region of CYCD3 weakened or completely 
abolished the interaction.  This observation suggests that the residues involved in the interaction 
of CYCD3 with ICK1 may be scattered in the linear sequence but are brought together when the 
protein is folded.  Although this observation provides a helpful clue on how CYCD3 interacts 
with ICK1, it may be difficult to identify a short region in CYCD3 that still retains the ability to 
interact with ICKs.   
Since limited results were obtained from the work on aptamer and CYCD3 interactions 
with ICKs, I then examined the expression, stability and possible phosphorylation of ICKs in 
plants, which forms the major part of my thesis.  All seven ICKs were expressed as GFP fusion 
proteins in transgenic plants.  The effects on plants, stability, interaction with the CDK complex 
and protein phosphorylation of the GFP-ICK proteins were investigated. The present results 
show that all seven ICKs can produce similar phenotypic effects, including smaller plant size, 
serrated leaves and altered floral morphology, when they are overexpressed in plants.  The levels 
of ICK fusion proteins are generally low.  For some transgenic plants, even though they 
displayed obvious ICK overexpression phenotypes, the fusion protein was not detectable, 
suggesting that ICK proteins are generally quite unstable. These results raise a question 
regarding the underlying mechanism for the instability of ICKs.  
Previously, it has been shown that the N-terminal region of ICK1 has a major role in its 
instability.  Since the ubiquitin-proteasome pathway is important for actively degrading certain 
proteins and this pathway has been shown to be important for cell cycle regulation, it is 
interesting to know whether ICK fusion proteins are degraded through the ubiquitin-proteasome 
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pathway.  MG132, a proteasome inhibitor, was used.  Following MG132 treatments, the levels of 
GFP-ICK1, GFP-ICK5, GFP-ICK6 and GFP-ICK7 showed an increase compared to the controls, 
indicating that the proteasome may be involved in the observed low protein levels for these 
proteins.  It is interesting that the effect was not ubiquitously observed for all ICKs.  Further, 
compared to the large amount of protein accumulation observed when the N-terminal region is 
removed from ICK1, the accumulation of GFP-ICK1 following MG132 treatment is modest.  It 
will be interesting to examine the possible differences among ICKs and why only moderate 
effects are observed following MG132 treatments considering that ICK proteins appear to be 
very unstable.  
Since protein phosphorylation may affect protein stability as well as protein-protein 
interactions and cellular localization, the possible phosphorylation of GFP-ICK fusion proteins 
was also analyzed in this study.  CIP was used to treat total protein extracts, and also proteins 
associated with the CDK complex after p13Suc1-affinity purification.  The results provide the first 
evidence that ICK1, ICK2, ICK5 and ICK6 are phosphorylated in vivo.   
It is clear that more work will be needed to better understand how plant CDK inhibitors 
are regulated at the post-transcriptional level. In one aspect, other techniques in addition to the 
CIP approach are needed to confirm that ICKs indeed undergo phosphorylation.  Techniques 
such as Western detection using phosphor-specific antibodies or mass spectrometry can be used 
since the usefulness of both techniques have been demonstrated in other studies.  The specific 
amino acid of ICK1 that is phosphorylated is also of interest to us.  As phosphorylation or 
dephosphorylation of a protein is linked to cellular functions and often to a cascade event, the 
discovery of the specific amino acids important for phosphorylation should provide us more 
insight on the regions of a protein important for its cellular functions.  In this regard, a series of 
HA-tag ICK1 deletion mutants have been constructed and transformed into Arabidopsis.  This 
series of constructs may aid us in narrowing down the region of ICK1 that undergoes 
phosphorylation. 
The observation that ICK7 protein is less stable after CIP treatment provides some 
evidence that phosphorylation status of ICK proteins may play a role in the stability of the 
protein.  The decreased level of ICK7 following CIP treatment may be due to rapid degradation 
of the protein through the ubiquitin-proteasome pathway.  More work will need to be conducted 
in the future to establish the link between ICK phosphorylation/dephosphorylation and 
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subsequent stability of the protein.  Although we have gained some important understanding on 
functions and regulation of the plant CDK inhibitors, further studies on the questions discussed 
above and related questions should provide a fuller picture on this family of plant cell cycle 
regulars, particularly in terms of posttranscriptional regulation.   
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